Sentence,class,file
Genetics  2006 ; 174:1811- 24; PMID:17028338 ; http://dx.doi.org/10.1534/ genetics.106.061374 66.,Non-OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Plant Physiol  2008 ; 148:436-54; PMID:18650403 ;  http://dx.doi.org/10.1104/pp.108.121038 67.,Non-OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Plant J  2009 ; 58:1-12; PMID:19054359 ;  http://dx.doi.org/10.1111/j.1365-313X.2008.03756.x,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Science  2009 ;  323:95-101; PMID:19095898 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Plant J  2009 ;  58:235-45; PMID:19077166 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Plant Cell  2006 ; 18:3706 - 20; PMID:17194769 ; http://dx.doi.org/10.1105/ tpc.106.044065 72.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Plant Physiol   2004 ; 135:1346 -66; PMID:15235117 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Plant Physiol  2004 ; 136:2556 - 76; PMID:15347784 ; http://dx.doi.org/10.1104/ pp.104.046482 74.,Non-OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Plant J   2006 ; 46:34-53; PMID:16553894 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
J Integr Plant Biol  2012 ; 54:471-85; PMID:22624950 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
EMBO J  2004 ; 23:2071 -82; PMID:15116068 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Plant Signal Behav  2007 ; 2:171-3; PMID:19704747 ;  http://dx.doi.org/10.4161/psb.2.3.3725 78.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Fungal Genet Biol 2001 ; 33 :69- 82; PMID:11456460 ; http://dx.doi.org/10.1006/ fgbi.2001.1275 79.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Annu Rev Plant Biol 2004 ; 55:315-40;  PMID:15377223 ; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Physiol Plant  1962 ; 15:473-97; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Mycologia  1998 ;  90:896-903; http://dx.doi.org/10.2307/376133182.,Non-OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Cell Res  2011 ;  21:101-13; http://zs.thulb.uni-jena.de/receive/ jportal_jparticle_00247947 .,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
Nucleic Acids  Res 2001 ; 29:e45; PMID:11328886 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/6e/psb-8-e26301.PMC4091356.pdf
"Plant Signaling & Behavior 2013; 8:e26664; PMID: 24105301; http://dx.doi.org/10.4161/psb.26664Nitric oxide mediates Cd-dependent induction   of signaling–associated genes Jagna Chmielowska-Bąk and Joanna Deckert* Department of Plant Ecophysiology; i nstitute of Experimental Biology, Faculty of Biology; a dam m ickiewicz u niversity; Poznań, Poland Keywords:  cadmium, heavy metal stress, gene expression, signaling, soybean the first reaction of plants to stress factors, including cadmium, is activation of signal transduction pathways leading  to the mobilization of defense mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
J  Plant Physiol 2013; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
Plant J  2009 ;  58:1-12; PMID:19054359 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
New Phytol  2008 ;  179:209-23; PMID:18422893 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
Plant  Physiol  2009 ; 149:1302 -15; PMID:19168643 ;  http://dx.doi.org/10.1104/pp.108.133348 5.,Non-OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
Plant Physiol  Biochem  2012 ; 58:124-34; PMID:22819859 ;  http://dx.doi.org/10.1016/j.plaphy.2012.06.0186.,OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
Planta  2010 ; 232:325-35; PMID:20449606 ;  http://dx.doi.org/10.1007/s00425-010-1177-y 7.,OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
J Plant Growth Regul   2010 ; 29:394-408; http://dx.doi.org/10.1007/ s00344-010-9151-2 10.,OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
Plant Physiol  2009 ; 150:217- 28; PMID:19261736 ; http://dx.doi.org/10.1104/ pp.108.133397 11.,Non-OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
Plant  Cell Environ  2006 ; 29:1956 -69; PMID:16930321 ;  http://dx.doi.org/10.1111/j.1365-3040.2006.01571.x13.,OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
J Exp Bot  2007 ; 58:659-71; PMID:17259646 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
Plant  Physiol  2004 ; 136:3276 -83; PMID :15448198 ;  http://dx.doi.org/10.1104/pp.104.045724 15.,Non-OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
Bioch Bioph Res Co  2003 ; 300:868-76;  http://dx.doi.org/10.1016/S0006-291X(02)02944-3 16.,OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
Phytochemistry  2010 ; 71:614-8; PMID:20116811 ;  http://dx.doi.org/10.1016/j.phytochem.2010.01.005 17.,OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
Plant Cell Environ 2013 ; 36:1-15; PMID :22621159 ;  http://dx.doi.org/10.1111/j.1365-3040.2012.02543.x 18.,OADS,/arxiv_data1/oa_pdf/5e/8e/psb-8-e26664.PMC4091360.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.115 Infect Chemother 2014;46(2):115-119 pISSN 2093-2340 · eISSN 2092-6448 Received:  July 11, 2013   Revised:  August 23, 2013  Accepted:  August 23, 2013 Corresponding Author : Jae-Phil Choi, MD Department of Internal Medicine, Seoul Medical Center, 156 Sinnae-ro,   Jungrang-gu, Seoul 131-795, Korea Tel: +82-2-2276-7813, Fax: +82-2-2276-7820 E-mail: dasole@hanmail.net Alternative Corresponding Author : Yeon Sang Jeong, MD Department of Internal Medicine, Seoul Medical Center, 156 Sinnae-ro,   Jungrang-gu, Seoul 131-795, Korea Tel: +82-10-9838-9590, Fax: +82-2-2276-7820 E-mail: nadapk@naver.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/54/ic-46-115.PMC4091363.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.115  •  Infect Chemother 2014;46(2) :115-119 www.icjournal.org  117 peared (Fig.,Non-OADS,/arxiv_data1/oa_pdf/0c/54/ic-46-115.PMC4091363.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.115  •  Infect Chemother 2014;46(2) :115-119 www.icjournal.org  119 NI.,Non-OADS,/arxiv_data1/oa_pdf/0c/54/ic-46-115.PMC4091363.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.77 Infect Chemother 2014;46(2):77-83 pISSN 2093-2340 · eISSN 2092-6448 Received: December 23, 2013   Revised:  February 15, 2014  Accepted: February 18, 2014 Corresponding Author : Jens M. Kittner 1st Medical Department University Medical Centre Mainz,  Langenbeckstr.",Non-OADS,/arxiv_data1/oa_pdf/01/fb/ic-46-77.PMC4091364.pdf
"1, 30625 Hannover, Germany Tel: +49-511-532-3897, Fax: +49-511-532-3190 E-mail: Jaeger.burkard@mh-hannover.de This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/fb/ic-46-77.PMC4091364.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.77  •  Infect Chemother 2014;46(2):7 7-83 www.icjournal.org  79 Mean and standard deviations (SD) and frequency were  used for continuous and categorical data.,OADS,/arxiv_data1/oa_pdf/01/fb/ic-46-77.PMC4091364.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.77  •  Infect Chemother 2014;46(2):7 7-83 www.icjournal.org  81 even more distress and stigmatization [29].,Non-OADS,/arxiv_data1/oa_pdf/01/fb/ic-46-77.PMC4091364.pdf
Available at: http://www.ncss.com.,Non-OADS,/arxiv_data1/oa_pdf/01/fb/ic-46-77.PMC4091364.pdf
Available at: http://www.rki.de/DE/Con - tent/Infekt/EpidBull/Archiv/2013/Ausgaben/11_13.pdf;js essionid=20538032501F6E683E6F2A45F0B234FE.2_ cid372?__blob=publicationFile.,Non-OADS,/arxiv_data1/oa_pdf/01/fb/ic-46-77.PMC4091364.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.77  •  Infect Chemother 2014;46(2):7 7-83 www.icjournal.org  83 stigmatization experience in atopic dermatitis and psori - atic patients.,Non-OADS,/arxiv_data1/oa_pdf/01/fb/ic-46-77.PMC4091364.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.84 Infect Chemother 2014;46(2):84-93 pISSN 2093-2340 · eISSN 2092-6448 Received: December 30, 2013   Revised:  February 10, 2014  Accepted: February 17, 2014 Corresponding Author : Yunsop Chong  Department of Laboratory Medicine and Research Institute of Bacterial Resistance,   Yonsei University College of Medicine, 250 Seongsan-ro, Seodaemun-gu, Seoul   120-752, Korea Tel: +82-2-2228-2446, Fax: +82-2-313-0908 Email: whonetkor@yuhs.ac This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/3c/ic-46-84.PMC4091365.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.2.84  •  Infect Chemother 2014;46(2):8 4-93 www.icjournal.org  85 Introduction Over recent years, the increasing prevalence of antimicrobial- resistant bacteria has become a serious problem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/db/3c/ic-46-84.PMC4091365.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.2.84  •  Infect Chemother 2014;46(2):8 4-93 www.icjournal.org  87 rates, 17% were resistant to cefotaxime/ceftriaxone, 8% to cef - tazidime and cefepime, and 10% to aztreonam.",Non-OADS,/arxiv_data1/oa_pdf/db/3c/ic-46-84.PMC4091365.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.84  •  Infect Chemother 2014;46(2):8 4-93 www.icjournal.org  89 almost two-fold higher than those from non-ICU patients.,Non-OADS,/arxiv_data1/oa_pdf/db/3c/ic-46-84.PMC4091365.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.84  •  Infect Chemother 2014;46(2):8 4-93 www.icjournal.org  91 pneumoniae  and P .,Non-OADS,/arxiv_data1/oa_pdf/db/3c/ic-46-84.PMC4091365.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.2.84  •  Infect Chemother 2014;46(2):8 4-93 www.icjournal.org  93 Gaynes RP , McGowan JE Jr; Intensive Care Antimicrobial  Resistance Epidemiology Project Hospitals .",Non-OADS,/arxiv_data1/oa_pdf/db/3c/ic-46-84.PMC4091365.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.103 Infect Chemother 2014;46(2):103-105 pISSN 2093-2340 · eISSN 2092-6448 Received:  January 24, 2013   Revised:  January 13, 2014  Accepted:  January 15, 2014 Corresponding Author : Hyoung-Shik Shin, MD Division of Infectious Disease, Department of Internal Medicine,   National Medical Center, 245 Eulji-ro, Jung-gu, Seoul 100-799, Korea Tel: +82-2-2260-7557, Fax: +82-2-2268-0803 Email: hyoungsshin@gmail.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/60/ic-46-103.PMC4091366.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.2.103  •  Infect Chemother 2014;46(2) :103-105 www.icjournal.org  105 These etiologies were ruled out in our case through labora - tory test results, which showed nonreactive RPR titer, increas - ing CD4 levels (411 cells/mm3), negative toxoplasmosis serol - ogy, and normal chest radiographs.",Non-OADS,/arxiv_data1/oa_pdf/6a/60/ic-46-103.PMC4091366.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.139 Infect Chemother 2014;46(2):139-140 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Jun Yong Choi, MD, PhD Department of Internal Medicine, Yonsei University College of Medicine,  50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: +82-2-2228-1974, Fax: +82-2-393-6884 Email: seran@yuhs.ac This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/ee/ic-46-139.PMC4091367.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.94 Infect Chemother 2014;46(2):94-102 pISSN 2093-2340 · eISSN 2092-6448 Received: March 14, 2014   Revised:  May 16, 2014  Accepted: May 18, 2014 Corresponding Author : Young Goo Song, MD, PhD Division of Infectious Disease, Department of Internal Medicine, Gangnam   Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro,   Gangnam-gu, Seoul 135-720, Korea Tel: +82-2-2019-3319, Fax: +82-2-3463-3882 E-mail: imfell@yuhs.ac This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/29/ic-46-94.PMC4091368.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.2.94  •  Infect Chemother 2014;46(2):9 4-102 www.icjournal.org  95 come including physiology and chronic health evaluation  (APACHE), the sequential organ failure assessment (SOFA),  and simplified acute physiology scores (SAPS).",Non-OADS,/arxiv_data1/oa_pdf/9b/29/ic-46-94.PMC4091368.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.94  •  Infect Chemother 2014;46(2):9 4-102 www.icjournal.org  97 models and the area under the curve (AUC) of the receiver  operating characteristic (ROC) curve was calculated for each  model to estimate the accuracy of the model for predicting  early mortality in GNB.,OADS,/arxiv_data1/oa_pdf/9b/29/ic-46-94.PMC4091368.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.94  •  Infect Chemother 2014;46(2):9 4-102 www.icjournal.org  99 and 3.2% of the survivor group ( P < 0.001).,Non-OADS,/arxiv_data1/oa_pdf/9b/29/ic-46-94.PMC4091368.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.2.94  •  Infect Chemother 2014;46(2):9 4-102 www.icjournal.org  101 specificity of 76.5% and 74.2%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/9b/29/ic-46-94.PMC4091368.pdf
Supplementary material Supplementary data including one table can be found with  this article online http://www.icjournal.org/src/sm/ic-46- 94-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/ic-46-94.PMC4091368.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.120 Infect Chemother 2014;46(2):120-124 pISSN 2093-2340 · eISSN 2092-6448 Received:  July 24, 2013   Revised:  September 3, 2013  Accepted:  September 3, 2013 Corresponding Author : Youn Jeong Kim, MD Departments of 1Internal Medicine, Seoul St. Mary’s hospital, The Catholic university  of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel: +82-2-2258-6073, Fax: +82-2-2258-1254 E-mail : muze1004@catholic.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/e8/ic-46-120.PMC4091369.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.2.120  •  Infect Chemother 2014;46(2) :120-124 www.icjournal.org  121 a 3-day history of polyuria, general weakness, and poor oral  intake.",Non-OADS,/arxiv_data1/oa_pdf/65/e8/ic-46-120.PMC4091369.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.2.120  •  Infect Chemother 2014;46(2) :120-124 www.icjournal.org  123 ae renal abscess, and this report also have summarized cases  of K. pneumoniae  infection with multiple foci, involving end - oophthlmitis, renal, liver or prostate infection and CNS infec - tion with concomitant liver abscess or spondylitis.",Non-OADS,/arxiv_data1/oa_pdf/65/e8/ic-46-120.PMC4091369.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.106 Infect Chemother 2014;46(2):106-109 pISSN 2093-2340 · eISSN 2092-6448 Received:  September 25, 2013   Revised:  November 28, 2013  Accepted:  January 14, 2014 Corresponding Author : Sang Taek Heo, MD Department of Internal Medicine, Jeju National University School of Medicine,   120 Jejudaehak-ro, Jeju 690-756, Korea Tel: +82-64-717-1296, Fax: +82-64-717-1131 E-mail: neosangtaek@naver.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/9b/ic-46-106.PMC4091370.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.106  •  Infect Chemother 2014;46(2) :106-109 www.icjournal.org  107 were  compared with V .,OADS,/arxiv_data1/oa_pdf/2e/9b/ic-46-106.PMC4091370.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.106  •  Infect Chemother 2014;46(2) :106-109 www.icjournal.org  109 the relationship between emerging V .,OADS,/arxiv_data1/oa_pdf/2e/9b/ic-46-106.PMC4091370.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.67 Infect Chemother 2014;46(2):67-76 pISSN 2093-2340 · eISSN 2092-6448 Received: October 10, 2013   Revised:  February 24, 2014  Accepted: March 17, 2014 Corresponding Author : Joon Young Song, MD, PhD Division of Infectious Diseases, Department of Internal Medicine,  Korea University Guro Hospital, Korea University College of Medicine,  148 Gurodong-ro, Guro-gu, Seoul 152-703, Korea Tel: +82-2-2626-3052, Fax: +82-2-2626-1105 E-mail: infection@korea.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/15/ic-46-67.PMC4091371.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.67  •  Infect Chemother 2014;46(2):6 7-76 www.icjournal.org  69 Results 1.,OADS,/arxiv_data1/oa_pdf/20/15/ic-46-67.PMC4091371.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.67  •  Infect Chemother 2014;46(2):6 7-76 www.icjournal.org  71 2.,Non-OADS,/arxiv_data1/oa_pdf/20/15/ic-46-67.PMC4091371.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.67  •  Infect Chemother 2014;46(2):6 7-76 www.icjournal.org  73 pathogen of acute respiratory infection.,Non-OADS,/arxiv_data1/oa_pdf/20/15/ic-46-67.PMC4091371.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.67  •  Infect Chemother 2014;46(2):6 7-76 www.icjournal.org  75 mit patients and take respiratory samples was made at the  discretion of the attending physician.,Non-OADS,/arxiv_data1/oa_pdf/20/15/ic-46-67.PMC4091371.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.141 Infect Chemother 2014;46(2):141-142 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Young Uh, MD  Department of Laboratory Medicine, Yonsei University Wonju College of Medicine,  20 Ilsan-ro, Wonju 220-701, Korea Tel: +82-33-741-1592, Fax: +82-33-731-0506, E-mail: u931018@yonsei.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/c9/ic-46-141.PMC4091372.pdf
Available at: http://www.who.int/drugre - sistance/WHO_Global_Strategy_English.pdf?ua=1 .,Non-OADS,/arxiv_data1/oa_pdf/14/c9/ic-46-141.PMC4091372.pdf
Available at: http://www.cdc.go.kr/CDC/ cms/content/58/12558_view.html.,Non-OADS,/arxiv_data1/oa_pdf/14/c9/ic-46-141.PMC4091372.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.110 Infect Chemother 2014;46(2):110-114 pISSN 2093-2340 · eISSN 2092-6448 Received:  April 12, 2013   Revised:  September 3, 2013  Accepted:  September 3, 2013 Corresponding Author : Heungsup Sung, MD  Department of Laboratory Medicine, Asan Medical Center, University of Ulsan   College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-4499, Fax: +82-2-478-0884 E-mail: sung@amc.seoul.kr  This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/1a/ic-46-110.PMC4091373.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.110  •  Infect Chemother 2014;46(2) :110-114 www.icjournal.org  111 tient had undergone coronary artery bypass graft (CABG) sur - gery for triple vessel disease 2 months prior to presentation.,Non-OADS,/arxiv_data1/oa_pdf/d1/1a/ic-46-110.PMC4091373.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.2.110  •  Infect Chemother 2014;46(2) :110-114 www.icjournal.org  113 pathogenicity, antimicrobial susceptibility, and the type of  disease produced, and thus needs to be done accurately.",Non-OADS,/arxiv_data1/oa_pdf/d1/1a/ic-46-110.PMC4091373.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.2.125 Infect Chemother 2014;46(2):125-138 pISSN 2093-2340 · eISSN 2092-6448 This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/9b/ic-46-125.PMC4091374.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.125  •  Infect Chemother 2014;46(2) :125-138 www.icjournal.org  127 Practice guidelines 1.,Non-OADS,/arxiv_data1/oa_pdf/96/9b/ic-46-125.PMC4091374.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.2.125  •  Infect Chemother 2014;46(2) :125-138 www.icjournal.org  129 one pathogen, but contiguous osteomyelitis can occur  through infection with a single pathogen or multiple patho - gens [5].",Non-OADS,/arxiv_data1/oa_pdf/96/9b/ic-46-125.PMC4091374.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.125  •  Infect Chemother 2014;46(2) :125-138 www.icjournal.org  131   3.,Non-OADS,/arxiv_data1/oa_pdf/96/9b/ic-46-125.PMC4091374.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.125  •  Infect Chemother 2014;46(2) :125-138 www.icjournal.org  133 2.,Non-OADS,/arxiv_data1/oa_pdf/96/9b/ic-46-125.PMC4091374.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.125  •  Infect Chemother 2014;46(2) :125-138 www.icjournal.org  135 7.,Non-OADS,/arxiv_data1/oa_pdf/96/9b/ic-46-125.PMC4091374.pdf
  http://dx.doi.org/10.3947/ic.2014.46.2.125  •  Infect Chemother 2014;46(2) :125-138 www.icjournal.org  137 2.,Non-OADS,/arxiv_data1/oa_pdf/96/9b/ic-46-125.PMC4091374.pdf
Supplementary material can be found with this article on - line http://www.icjournal.org/src/sm/ic-46-125-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/9b/ic-46-125.PMC4091374.pdf
"Plant Signaling & Behavior 2013; 8:e26956; PMID: 24184917; http://dx.doi.org/10.4161/psb.26956N-glycosylation and dimerization regulate the  PtrMAN6 enzyme activity that may modulate  generation of oligosaccharide signals Yunjun Zhao, Qian Zhang, Luxia Yuan, r ui Zhang, and Laigeng Li* national Key Laboratory of Plant m olecular Genetics; C aS Key Laboratory of Synthetic Biology; i nstitute of Plant Physiology and Ecology; Shanghai i nstitutes for Biological  Sciences; Chinese a cademy of Sciences; Shanghai, P r China Keywords:  PtrMAN6, N-glycosylation, Dimerization, GGMOs, Redox Abbreviations: GGMOs, Galactoglucomannan oligosaccharides; MAN, mannan endo-hydrolase Ptrman 6 is a plant mannan endo-hydrolase involved in modulating cell expansion and cell wall thickening in Populus   developing xylem.",Non-OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Planta 1995; 196:420-4; http://dx.doi.org/10.1007/ BF00203638 2.,Non-OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Plant Physiol  2006 ; 142:696- 709; PMID:16891547 ; http://dx.doi.org/10.1104/ pp.106.085712 3.,Non-OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Plant J  2013 ; 74:473-85; PMID:23384057 ;  http://dx.doi.org/10.1111/tpj.121376.,OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Curr Opin Chem Biol 1999 ; 3:643- 9; PMID:10600722 ; http://dx.doi.org/10.1016/ S1367-5931(99)00021-6 7.,OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Glycobiology  1993 ; 3:97- 130; PMID:8490246 ; http://dx.doi.org/10.1093/ glycob/3.2.97 8.,Non-OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Biochemistry   2000 ; 39:7032 ; PMID:10841785 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Curr Opin Biotechnol   1995 ; 6:203-8; PMID:7734749 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Plant Physiol  2002 ; 130:1254 - 62; PMID:12427992 ; http://dx.doi.org/10.1104/ pp.011890 11.,Non-OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Protein Sci   2005 ; 14:1233 -41; PMID:15840830 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
J Exp Bot 2012 ; 63:3976 -88;  PMID:22553284 ; http://dx.doi.org/10.1093/jxb/ ers096 13.,OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Plant Signal Behav  2013 ; 8:8; PMID:23425848 ;  http://dx.doi.org/10.4161/psb.23681 14.,OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
Nature   2003 ; 422:442-6; PMID:12660786 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
J Integr Plant Biol   2010 ; 52:556-67; PMID:20590986 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
J  Integr Plant Biol  2008 ; 50:1518-29; PMID:19093970 ;  http://dx.doi.org/10.1111/j.1744-7909.2008.00769.xFigure 2 (see previous page).,OADS,/arxiv_data1/oa_pdf/f0/38/psb-8-e26956.PMC4091382.pdf
"Plant Signaling & Behavior 2014; 9:e27639; PMID: 24394987; http://dx.doi.org/10.4161/psb.27639Comprehensive analysis of protein interactions  between JAZ proteins and bHLH transcription  factors that negatively regulate jasmonate  signaling Yuko Sasaki-Sekimoto1,†,‡,*, hikaru Saito2,‡, Shinji m asuda3,4, Ken Shirasu5, and h iroyuki o hta3,4 1riKEn Plant Science Center; t surumi-ku, Yokohama Kanagawa, Japan; 2Graduate School of Bioscience and Biotechnology; t okyo i nstitute of t echnology; nagatsuta-cho  midori-ku Yokohama Kanagawa, Japan; 3Center for Biological r esources and i nformatics; t okyo i nstitute of t echnology; n agatsuta-cho m idori-ku Yokohama Kanagawa,  Japan; 4Earth-Life Science i nstitute; t okyo i nstitute of t echnology; o okayama m eguro-ku; t okyo, Japan; 5riKEn Center for Sustainable r esource Science; Suehiro-cho,  tsurumi-ku, Yokohama Kanagawa, Japan †Current address: Earth-Life Science i nstitute; t okyo i nstitute of t echnology; o okayama m eguro-ku, t okyo, Japan ‡these authors contributed equally to this article.",OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
"Alignment of the amino acid sequences of JAM1, JAM2,  JAM3, MYC2, MYC3, and MYC4 The amino acid sequences of JAM1 and its closely related  bHLH proteins were aligned using the ClustalW program  (http://clustalw.ddbj.nig.ac.jp/).29 Identical and similar amino  acids are shaded black and gray, respectively, using the software  GeneDoc ver 2.7 (http://www.nrbsc.org/gfx/genedoc/).",OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Nuclear localization signals were predicted by cNLS Mapper  (http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Supplementary Material Supplementary material may be found here:   http://www.landesbioscience.com/journals/psb/article/27639 / References 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Curr Opin Plant  Biol 2005; 8:369-77;  PMID:15939667 ; http://dx.doi.org/10.1016/j.pbi.2005.05.008 2.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Plant  Physiol  2008 ; 146:832-8; PMID:18316637 ; http://dx.doi.org/10.1104/pp.107.115683 3.,Non-OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Annu Rev Plant Biol  2009 ; 60:183-205; PMID:19025383 ; http://dx.doi.org/10.1146/ annurev.arplant.043008.092007 4.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
DNA Res  2001 ; 8:153-61;  PMID:11572481 ; http://dx.doi.org/10.1093/dnares/8.4.153,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Plant Mol Biol  2005 ; 58:497-513; PMID:16021335 ;  http://dx.doi.org/10.1007/s11103-005-7306-5 6.,Non-OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Plant J  2005 ;  44:653-68; PMID:16262714 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Plant Cell  2007 ; 19:2225 -45;  PMID:17616737 ; http://dx.doi.org/10.1105/ tpc.106.048017 9.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Ann Bot   2007 ; 100:681-97; PMID:17513307 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Sci Signal  2010 ;  3:cm3; PMID:20159849 ; http://dx.doi.org/10.1126/ scisignal.3109cm3 12.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Nature  2007 ; 448:661- 5; PMID:17637677 ; http://dx.doi.org/10.1038/ nature05960 14.,Non-OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Plant Cell  2004 ; 16:1938 - 50; PMID:15208388 ; http://dx.doi.org/10.1105/ tpc.022319 16.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Curr  Opin Plant Biol  2008 ; 11:486-94; PMID:18653378 ;  http://dx.doi.org/10.1016/j.pbi.2008.06.003 17.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Curr Opin Plant Biol  2008 ; 11:428-35;  PMID:18583180 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Plant Cell  2011 ; 23:701- 15; PMID:21335373 ; http://dx.doi.org/10.1105/ tpc.110.080788 19.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Mol Plant   2011 ; 4:279-88; PMID:21242320 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
J Exp Bot   2011 ; 62:2143 -54; PMID:21321051 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Plant Physiol  2013 ; 163:291-304;  PMID:23852442 ; http://dx.doi.org/10.1104/ pp.113.220129 22.,Non-OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
PLoS Genet  2013 ; 9:e1003653 ;  PMID:23935516 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Plant Cell  2013 ; 25:1641 - 56; PMID:23673982 ; http://dx.doi.org/10.1105/ tpc.113.111112 24.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Plant Signal Behav   2013 ; 8:e26473 ; PMID:24056034 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Plant J  2009 ; 59:77-87; PMID:19309455 ;  http://dx.doi.org/10.1111/j.1365-313X.2009.03852.x 26.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Proc Natl Acad Sci U S A  2008 ;  105:7100 -5; PMID:18458331 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
Nucleic Acids Res  1994 ; 22:4673 -80;  PMID:7984417 ; http://dx.doi.org/10.1093/ nar/22.22.4673 30.,Non-OADS,/arxiv_data1/oa_pdf/a3/14/psb-9-e27639.PMC4091383.pdf
"Plant Signaling & Behavior  2014; 9:e27972; PMID: 24521825; http://dx.doi.org/10.4161/psb.27972The evolutionary context of root epidermis cell  patterning in grasses (Poaceae) Marek Marzec1,*, Michael Melzer2, and i wona Szarejko1 1Department of Genetics; Faculty of Biology and e nvironmental Protection; University of Silesia; Katowice, Poland; 2Department of Physiology and Cell Biology; Leibniz  institute of Plant Genetics and Crop Plant Research ( iPK); Gatersleben, Germany Keywords:  atrichoblast, barley ( Hordeum vulgare ), Brachypodium ditachyon , cell pattern, differentiation, epidermis, evolution,  Poaceae, rice ( Oryza sativa ), root hair, trichoblast in the last century, the mechanism for establishing the root  epidermal pattern in grasses was proposed as a differentiating  trait that can be used in taxonomic studies and as a useful  tool to indicate the relationships between genera.",OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Ann Bot  (Lond)  1996 ; 77:547-53; http://dx.doi.org/10.1093/ aob /77.6.547 3.,Non-OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
J Exp Bot   2001 ; 52:413-7; PMID:11326047 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
J Plant  Growth Regul  2002 ; 21:383-415; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Trends Plant Sci   2010 ; 15:641-50; PMID:20851035 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Plant Soil  2011 ; 346:1-14; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
New Phytol   2011 ; 192:601-10; PMID:21848982 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Nat Rev Mol Cell Biol  2011 ; 12:177- 88; PMID:21346731 ; http://dx.doi.org/10.1038/ nrm3064 12.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Curr Opin Plant Biol  2010 ; 13:661- 9; PMID:20970370 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Sex Plant Reprod  2011 ; 24:161-9;  PMID:21225434 ; http://dx.doi.org/10.1007/ s00497-010-0160-x 14.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Plant Cell  2011 ; 23:3260 -75;  PMID:21963668 ; http://dx.doi.org/10.1105/ tpc.111.088583 15.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
J Exp Bot  2013 ; 64:5145 -55; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Planta  2013 ; 237:1227 -39; PMID:23334469 ;  http://dx.doi.org/10.1007/s00425-013-1838-8 17.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Plant J   2008 ; 54:888-98; PMID:18298667 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Proc Natl Acad Sci U S  A 1939 ; 25:248-52; PMID:16577890 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Am J Bot  1957 ; 44:596-601; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
2012 ; http://www.tropicos.org/ 24.,Non-OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Bull Torrey Bot Club  1943 ; 70:182-3;  http://dx.doi.org/10.2307/2481370 25.,Non-OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
Plant Signal  Behav  2014 ; 9; PMID:24476959 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/d3/psb-9-e27972.PMC4091389.pdf
"Public Health Agency of Canada, 2010. http://www.phac-aspc.gc.ca/hp-ps/dca-dea/publications/hbsc-mental-mentale/assets/pdf/hbsc- mental-mentale-eng.pdf 20.",Non-OADS,/arxiv_data1/oa_pdf/94/85/bmjopen-2014-004919.PMC4091391.pdf
http://www12.statcan.gc.,Non-OADS,/arxiv_data1/oa_pdf/94/85/bmjopen-2014-004919.PMC4091391.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005005).,Non-OADS,/arxiv_data1/oa_pdf/e8/92/bmjopen-2014-005005.PMC4091392.pdf
18. http://srtr.transplant.hrsa.gov/annual_reports/2011/pdf/01_kidney_12.,OADS,/arxiv_data1/oa_pdf/e8/92/bmjopen-2014-005005.PMC4091392.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005634).,Non-OADS,/arxiv_data1/oa_pdf/eb/2b/bmjopen-2014-005634.PMC4091393.pdf
"This will involve searching relevant organisational websites (AAST , American College ofS u r g e o n s ,A m e r i c a nT r a u m aS o c i e t y ,A u s t r a l a s i a nT r a u m a Society, British Trauma Society, CAGS, Critical Care Society, EAST , International Trauma Anaesthesia, National Trauma Research Institute, the Society of Trauma Nurses, TAC,http://www.trauma.org, and the WTA), Google Scholar (the ﬁrst 10 web pages) and two clinical trial registries (http://www.clinicaltrials.gov and http://www.controlled-trials.com) using various combinations of the fol- lowing key terms: trauma ,injury ,damage control ,damage control surgery ,bailout surgery ,abbreviated surgery ,planned reoperation , indication and predictor .",Non-OADS,/arxiv_data1/oa_pdf/eb/2b/bmjopen-2014-005634.PMC4091393.pdf
"Textbooks of interest will be identi ﬁed by searching for relevant books listed in Access Medicine (http://accessmedicine.com), the University of Calgary Ebrary (which contains more than 30 000 book titles, and is located at http://site.ebrary.com.ezproxy.lib.ucalgary.ca/lib/ucalgary/h ome.action), and within the surgery category of Books@Ovid (http://www.ovid.com).",Non-OADS,/arxiv_data1/oa_pdf/eb/2b/bmjopen-2014-005634.PMC4091393.pdf
http://www.nlm.nih.gov/archive/20060905/nichsr/ehta/chapter3.html#COSI (accessed 10 Dec 2013).,OADS,/arxiv_data1/oa_pdf/eb/2b/bmjopen-2014-005634.PMC4091393.pdf
To view these files please visit the journal(http://dx.doi.org/10.1136/ bmjopen-2013-004782).,Non-OADS,/arxiv_data1/oa_pdf/23/8f/bmjopen-2013-004782.PMC4091396.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/23/8f/bmjopen-2013-004782.PMC4091396.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005535).,Non-OADS,/arxiv_data1/oa_pdf/53/9e/bmjopen-2014-005535.PMC4091397.pdf
"In the interest of openness and transparency, we createda publicly accessible website (http://www.rxarchives.",Non-OADS,/arxiv_data1/oa_pdf/53/9e/bmjopen-2014-005535.PMC4091397.pdf
Data sharing statement All clinical trial summaries that were analysed in this study have been uploaded by the first author (SH) to a publicly accessiblewebsite (http://www.rxarchives.com) for download.,Non-OADS,/arxiv_data1/oa_pdf/53/9e/bmjopen-2014-005535.PMC4091397.pdf
2012. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM227351.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/53/9e/bmjopen-2014-005535.PMC4091397.pdf
"New York Times 2012 April 12, 2012. http://www.nytimes.com/2012/04/12/business/drug-giant-is-fined-1 –2-billion-in-arkansas.html 12.",Non-OADS,/arxiv_data1/oa_pdf/53/9e/bmjopen-2014-005535.PMC4091397.pdf
New York Times 2012. http://www.nytimes.com/2012/07/03/business/glaxosmithkline-agrees-to-pay-3-billion-in-fraud-settlement.html?pagewanted=all 13.,Non-OADS,/arxiv_data1/oa_pdf/53/9e/bmjopen-2014-005535.PMC4091397.pdf
2012; Available from: http://www.citizen.org/documents/2073.pdf (accessed 21 Oct 2013).14.,Non-OADS,/arxiv_data1/oa_pdf/53/9e/bmjopen-2014-005535.PMC4091397.pdf
2012. http://blogs.plos.org/speakingofmedicine/2012/03/23/silent-takedown-of-the-pharma-trials-database%E2%80%A6and-more/ 23.,Non-OADS,/arxiv_data1/oa_pdf/53/9e/bmjopen-2014-005535.PMC4091397.pdf
2014. http://news.yale.edu/2014/01/30/yale-program-s-agreement-johnson-johnson-allows-broad-access-clinical-trial-data 43.,Non-OADS,/arxiv_data1/oa_pdf/53/9e/bmjopen-2014-005535.PMC4091397.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/4a/bmjopen-2014-004856.PMC4091399.pdf
2011. http://www.bapm.org/publications/documents/guidelines/CatsofcarereportAug11.pdf (accessed 12 Jun 2012).,Non-OADS,/arxiv_data1/oa_pdf/7a/4a/bmjopen-2014-004856.PMC4091399.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005952).,Non-OADS,/arxiv_data1/oa_pdf/7c/94/bmjopen-2014-005952.PMC4091400.pdf
"Rare Diseases 2014; 2:e28859; http://dx.doi.org/10.4161/rdis.28859 Addendum to: Mohan RD, Dialynas G, Weake VM, Liu J, Martin-Brown S, Florens L, Washburn MP , Workman JL, Abmayr SM.",Non-OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Genes Dev 2014; 28:259-72; PMID:24493646; http://dx.doi.org/10.1101/gad.225151.113,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Nature 2010; 466:1069- 75; PMID:20740007 ; http://dx.doi.org/10.1038/ nature09320 2.,Non-OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Hum  Mol Genet 2003; 12:R173-86; PMID:14504263 ;  http://dx.doi.org/10.1093/hmg/ddg295 3.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Nat Rev Neurosci  2004; 5:641-55;  PMID :15263894 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
J Neurol 2001; 248:911- 4; PMID:11697534 ; http://dx.doi.org/10.1007/ s004150170082 5.,Non-OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Nat Genet  1997; 17:65-70;  PMID:9288099 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Hum Mol Genet 1998; 7:165-70;  PMID:9425222 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Eur J Hum Genet 2004; 12:2-15; PMID:14571264 ; http://dx.doi.org/10.1038/ sj.ejhg.5201108 8.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Neurology 1994; 44:1441- 7; PMID:8058146 ; http://dx.doi.org/10.1212/ WNL.44.8.1441 9.,Non-OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Trends Cell Biol  2012; 22:177-84;  PMID:22196215 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Cell Cycle 2008; 7:1522- 4; PMID:18469533 ; http://dx.doi.org/10.4161/ cc.7.11.5962 11.,Non-OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Mol Cell 2009; 35:352-64; PMID:19683498 ;  http://dx.doi.org/10.1016/j.molcel.2009.06.01512.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
EMBO Rep 2011; 12:924-30;  PMID:21779003 ; http://dx.doi.org/10.1038/ embor.2011.140 13.,Non-OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Curr Opin Cell Biol 2010; 22:374-82; PMID:20363118 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Mol Syst Biol 2011; 7:503; PMID:21734642 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Science 2010; 328:1025- 9; PMID:20395473 ; http://dx.doi.org/10.1126/ science.1190049 16.,Non-OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Cell 2010; 141:606-17; PMID:20434206 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
EMBO J 2008; 27:394-405; PMID:18188155 ;  http://dx.doi.org/10.1038/sj.emboj.7601966Figure 2.  model for polyglutamine-expansion-mediated disruption of S aGa function.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
PLoS One 2012; 7:e39456;  PMID:22745758 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
J Neurosci 2007; 27:2483- 92; PMID:17344386 ; http://dx.doi.org/10.1523/ JNEUROSCI.5453-06.2007 22.,Non-OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Mol Neurodegener  2013; 8:42;  PMID:24160175 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Hum Mol Genet 2013; 22:890-903;  PMID:23197655 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Hum Mol Genet 2012; 21:394- 405; PMID:22002997 ; http://dx.doi.org/10.1093/ hmg/ddr474 26.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
J Biol Chem 2013; 288:34266- 75; PMID:24129567 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
Genes Dev  2014; 28:259-72;  PMID:24493646 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7a/a1/rdis-2-e28859.PMC4091419.pdf
"Plant Signaling & Behavior 2014; 9:e28242; PMID: 24614623; http://dx.doi.org/10.4161/psb.28242Phylogenetic analysis of the expansion   of the MATH-BTB  gene family in the grasses martina Juranić1 and t homas Dresselhaus2,* 1Department of m olecular Biology; Faculty of Science and m athematics; u niversity of Zagreb; Zagreb, Croatia;   2Cell Biology and Plant Biochemistry; Biochemie-Zentrum r egensburg; u niversity of r egensburg; r egensburg, Germany Keywords:  phylogeny, E3 ligases, MATH-BTB, MAB1, synteny, tandem/segmental gene duplication, maize Abbreviations:  BTB, Bric-A-Brac, Tramtrack, Broad Complex protein domain; E1-E5, MATH-BTB subclades of the expanded clade;  MATH, Meprin and TRAF Homology protein domain math -BtB proteins are known to act as substrate-specific adaptors of cullin3 (C uL3)-based ubiquitin E3 ligases to  target protein for ubiquitination.",OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Genome Biol 2005; 6:R82;   PMID:16207353 ; http://dx.doi.org/10.1186/ gb-2005-6-10-r82 2.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
EMBO J  2013; 32:2307-20;  PMID :23912815 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
J Biol Chem 2005; 280:18810-21;   PMID :15749712 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Plant Cell 2007; 19:2329-48;   PMID:17720868 ; http://dx.doi.org/10.1105/ tpc.107.051300 6.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
FEBS J 2009;  276:6624-35;  PMID:19843165 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Dev Cell 2011; 21:1116-28; PMID:22172674 ;  http://dx.doi.org/10.1016/j.devcel.2011.10.0188.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Plant Cell 2012; 24:4974-91; PMID:23250449 ;  http://dx.doi.org/10.1105/tpc.112.107169 10.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Mol Biol Evol 2010; 27:221-4; PMID:19854763 ;  http://dx.doi.org/10.1093/molbev/msp259 11.,Non-OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Nature 2012; 488:213-7; PMID :22801500 ;  http://dx.doi.org/10.1038/nature11241 12.,Non-OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
BMC Evol Biol 2006; 6:62; PMID:16914031 ;  http://dx.doi.org/10.1186/1471-2148-6-62 13.,Non-OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
BMC Genomics  2009; 10:317;  PMID:19607679 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Nature 2008; 453:729-31;  PMID:18528383 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Genome Res 2006; 16:1017-30; PMID:16825662 ;  http://dx.doi.org/10.1101/gr.508980616.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
PLoS One 2013; 8:e68672;   PMID:23904908 ; http://dx.doi.org/10.1371/jour - nal.pone.0068672 17.,Non-OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Plant Physiol 2005; 137:83-93;  PMID :15618422 ;  http://dx.doi.org/10.1104/pp.104.052654 18.,Non-OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Nature 2010; 463:763- 8; PMID:20148030 ; http://dx.doi.org/10.1038/ nature08747 20.,Non-OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Brief  Bioinform 2009; 10:619-30; PMID:19720678 ;  http://dx.doi.org/10.1093/bib/bbp037 21.,Non-OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
Plant J  1994; 5:605-10;  PMID:8012409 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/b9/kpsb-09-04-10928242.PMC4091423.pdf
"Plant Signaling & Behavior 2014; 9:e28466; PMID: 24614164; http://dx.doi.org/10.4161/psb.28466 Addendum to: Hoepflinger MC, Geretschlaeger A, Sommer A, Hoeftberger M, Nishiyama T, Sakayama H, Hammerl P , Tenhaken R, Ueda T, Foissner I. Molecular and biochemical analysis of the first ARA6 homologue, a RAB5 GTPase, from green algae.",OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
J Exp Bot 2013; 64:5553–68; PMID: 24127512;   http://dx.doi.org/10.1093/jxb/ert322,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
EMBO J 2001; 20:4730-41; PMID :11532937 ;  http://dx.doi.org/10.1093/emboj/20.17.4730 5.,Non-OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Plant Cell 2003; 15:1057-70; PMID:12724533 ;  http://dx.doi.org/10.1105/tpc.0097796.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Dev Cell 2006; 10:137- 50; PMID:16399085 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
J Plant Res  2009; 122:21-30;  PMID:19082690 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
J Exp Bot 2013; 64:5553-68; PMID:24127512 ;  http://dx.doi.org/10.1093/jxb/ert32210.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Plant Cell 2010; 22:1344- 57; PMID:20435907 ; http://dx.doi.org/10.1105/ tpc.109.072637 11.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Plant Cell Physiol 2011;  52:1274-88;  PMID:21659328 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Nature 2008; 451:835-40;  PMID:18273019 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Mol Biol Cell 2013; 24:1593-601;   PMID :23515225 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Cell Struct Funct  2004; 29:49-65;  PMID :15342965 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Nucleic Acids Res 2010; 38:W695-9; PMID:20439314 ;  http://dx.doi.org/10.1093/nar/gkq313 18.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Nucleic Acids Res 2010; 38:W14-8;   PMID:20439312 ; http://dx.doi.org/10.1093/nar/ gkq321 19.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Nat Methods 2012; 9:772;   PMID:22847109 ; http://dx.doi.org/10.1038/ nmeth.2109 20.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Syst Biol 2003;  52:696-704;  PMID:14530136 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
BMC Evol  Biol 2007; 7:214; PMID:17996036 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
"Tracer v1.4, Available  from http://beast.bio.ed.ac.uk/Tracer .",OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Bioinformatics 2006;  22:2688-90;  PMID:16928733 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Org Divers Evol 2012; 12:335-7; http://dx.doi.org/10.1007/s13127-011-0056-0 25.,Non-OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
Version 1.3.1. http://tree.bio.ed.ac.uk/ software/figtree/,Non-OADS,/arxiv_data1/oa_pdf/84/2a/kpsb-09-04-10928466.PMC4091427.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/c8/jgenv01p0029.PMC4091428.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b6/bb/jgenv01p0056.PMC4091429.pdf
This is an open- access article distributed under the ter ms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/47/07/jgenv01p0001.PMC4091430.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
The database and genomic views are freely available online at:  http://www.integratomics- time.com/fat_deposition .,OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
"All relevant  publications were identified after searching PubMed  (http://www.ncbi.nlm.nih.gov/pubmed) and Web of Science (http://apps.w ebofknowledge.com/), with  key phrases, such as gene, genetics, epigenetics,  non- coding RNA, microRNA, obesity, adipose tissue,  marbling, fat deposition, adipogenesis, human, cattle, rat, and mouse.",OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
"Obesity -associated loci were also ex- tracted from the follo wing databases: Human obesity  gene map (OGM ) [8], GeneCards, version 3.07  (http://www.genecards.org), Mouse Genome Infor-matics, release 4.42 (MGI: http://www.informatics.",Non-OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
"To analyze genomic overlaps of obesity  as- sociated loci, QTL were downloaded  from Rat Ge- nome Database, release date: October 2011 (RGD: http://rgd.mcw.edu/) [28], and Animal QTL Dat a- base, release 15 ( http://www.animalgenome.",OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
Gene nomenclature was based on  the HUGO Gene Nomenclature Guidelines  (http://www.genenames.org).,OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
"MiRNA nomenclature  was adjusted ac cording to the miRBase, release 18  (http://microrna.sanger.ac.uk/).",OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
Genomic views (graphical overview of the chromosomal locations) of obesity associated loci were constructed using the web -based interactive visualization tool Flash GViewer  (http://gmod.org/wiki/Flashgviewer/) develope d  by the GMOD project.,OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
The database is freely avail a- ble on the Web site at http://www.integratomics -  time.com/fat_deposition.,OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
The newly submitted information will be reviewed by curators before releasing to the public (http://www.integratomics -time.com/fat_   deposition/add _genes).,Non-OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
"Comparative genomic distribution of fat depos i- tion associated loci   An integrative, comparative -genomics approach  allowed us to join obesity -associated information for  various species regardless of the study approach, and  to present collected loci from human and animals in the form of a single species (human, mouse, and ca t- tle) genomic view available at http://www.integratomics -time.com/fat_deposition /genomic_view/.",Non-OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
"Input data  set consisted of 1,676 genes (protein coding and  miRNA genes) and can be accessed on the web page  http://www.integratomics -time.com/fat_deposition /genomic_view/.",OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
http://www.jgenomics .com/v01p0045 s1.pdf   Acknowledgements   This work was supported by the Slovenian R e- search Agency (ARRS) through  the Research pro- gramme  Comparative genomics and genome biod i- versity (P4 -0220).,OADS,/arxiv_data1/oa_pdf/52/1d/jgenv01p0045.PMC4091431.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5f/25/jgenv01p0039.PMC4091432.pdf
This is an open- access article distributed under the terms of the Creative Comm ons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/9e/jgenv01p0013.PMC4091433.pdf
This is an open- access article distributed under the terms of the Creative Co mmons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7b/fa/jgenv01p0022.PMC4091434.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/af/e9/jgenv01p0005.PMC4091435.pdf
"44pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.44 Annals of Surgical Treatment and ResearchCASE REPORT Spontaneous splenic rupture in Plasmodium vivax malaria Kwang Min Kim, Byung Koo Bae, Sung Bae Lee Department of Surgery, The Armed Forces Capital Hospital, Seongnam, Korea INTRODUCTION Malaria is a parasitic disease caused by infection with  Plasmodium  species of phylum protozoa and subphylum  haplosporea that resides in red blood cells.",Non-OADS,/arxiv_data1/oa_pdf/a9/13/astr-87-44.PMC4091436.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Malaria can present with various clinical symptoms and complications.",Non-OADS,/arxiv_data1/oa_pdf/a9/13/astr-87-44.PMC4091436.pdf
" Annals of Surgical Treatment and Research 51pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.51 Annals of Surgical Treatment and ResearchERRATUM ERRA TUM: Correction for the number of the recruited patients and the participating institutions Prospective randomized controlled trial (phase III) to  comparing laparoscopic distal gastrectomy with open  distal gastrectomy for gastric adenocarcinoma (KLASS 01) Hyung-Ho Kim, Sang-Uk Han1, Min-Chan Kim2, Woo Jin Hyung3, Wook Kim4, Hyuk-Joon Lee5, Seung Wan Ryu6,  GyuSeok Cho7, Chan Young Kim8, Han-Kwang Yang5, Do Joong Park, Kyo Young Song9, Sang IL Lee10, Seong  Yeob Ryu11, Joo Ho Lee12; Korean Laparoscopic Gastrointestinal Surgery Study (KLASS) Group Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam,  1Department of Surgery, Ajou University School of Medicine, Suwon, 2Department of Surgery, Dong-A University College of  Medicine, Busan, 3Department of Surgery, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul,  4Department of Surgery, Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, 5Department of  Surgery, Cancer Research Institute, Seoul National University, Seoul, 6Department of Surgery, Keimyung University School of  Medicine, Daegu, 7Department of Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of  Medicine, Bucheon, 8Department of Surgery, Chonbuk National University Hospital, Jeonju, 9Department of Surgery, Seoul St.  Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, 10Department of Surgery, Chungnam National  University Hospital, Daejeon, 11Department of Surgery, Chonnam National University Medical School, Gwangju, 12Department of  Surgery, Ewha Womans University Mokdong Hospital, Seoul, Korea To the Editor  Thank you for publication our clinical trial note entitled “Pro - spective randomized controlled trial (phase III) to comparing  laparoscopic distal gastrectomy with open distal gastrectomy  for gastric adenocarcinoma (KLASS 01)” in volume 84(2) of the  February 2013 issue.",Non-OADS,/arxiv_data1/oa_pdf/1e/c9/astr-87-51.PMC4091437.pdf
"Thus those were described as  1,415 patients (704 underwent LADG and 711 underwent ODG)  and 12 institutions in the abstract, Study setting, Progress and http://dx.doi.org/10.4174/jkss.2013.84.2.123 J Korean Surg Soc 2013;84(2):123-30 Fig.",OADS,/arxiv_data1/oa_pdf/1e/c9/astr-87-51.PMC4091437.pdf
" Annals of Surgical Treatment and Research 41pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.41 Annals of Surgical Treatment and ResearchCASE REPORT Delayed hepatic rupture after radiofrequency ablation for  colorectal hepatic metastasis: management with  transcatheter arterial embolization Il Soo Chang, Young Jun Kim, Sang Woo Park, Hee Sun Park, Hae Jeong Jeon, Seong-Hwan Chang1, Dae-Yong  Hwang1 Departments of Radiology and 1Surgery, Konkuk University School of Medicine, Seoul, Korea INTRODUCTION The liver is the most common site of distant metastasis in  colorectal cancer and 50% of all patients with colon cancer  ultimately develop liver involvement [1].",Non-OADS,/arxiv_data1/oa_pdf/5a/f1/astr-87-41.PMC4091438.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Intraperitoneal bleeding after radiofrequency ablation (RFA) is the most common major vascular complication due to direct  needle injury to a vessel or liver capsule.",Non-OADS,/arxiv_data1/oa_pdf/5a/f1/astr-87-41.PMC4091438.pdf
" Annals of Surgical Treatment and Research 1pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.1 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Transanal natural orifice transluminal endoscopic surgery  total mesorectal excision in animal models: endoscopic  inferior mesenteric artery dissection made easier by a  retroperitoneal approach Sun Jin Park, Dae Kyung Sohn1, Tae Young Chang1, Yunho Jung2, Hyung Jin Kim3, Young Ill Kim4, Ho-Kyung  Chun5; Korea Natural Orifice Transluminal Endoscopic Surgery (K-NOTES) Study Group Department of Surgery, Kyung Hee University School of Medicine, Seoul, 1Research Institute and Hospital, National Cancer  Center, Goyang, 2Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University  College of Medicine, Cheonan, 3Department of Surgery, St. Vincent's Hospital, The Catholic University of Korea College of  Medicine, Suwon, 4Chung-Cheong Surgery Clinic, Daejeon, 5Department of Surgery, Kangbuk Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul, Korea INTRODUCTION Natural orifice transluminal endoscopic surgery (NOTES)  is a new method of using a natural orifice to access the intra-abdominal space.",Non-OADS,/arxiv_data1/oa_pdf/56/90/astr-87-1.PMC4091439.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose: We report the performance of natural orifice transluminal endoscopic surgery (NOTES) low anterior resection in  animals using transanal total mesorectal excision (TME) with laparoscopic assistance and endoscopic inferior mesenteric  artery (IMA) dissection.",Non-OADS,/arxiv_data1/oa_pdf/56/90/astr-87-1.PMC4091439.pdf
Procedure of NOTES low anterior resection (Video  clip can be operated via http://www.astr.or.kr/src/sm/astr-87- 1-s001.mpg).,Non-OADS,/arxiv_data1/oa_pdf/56/90/astr-87-1.PMC4091439.pdf
"22pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.22 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Balanced approach can help initial outcomes: analysis of  initial 50 cases of a new liver transplantation program in  East Asia Dong-Sik Kim, Young-Dong Yu, Sung-Won Jung, Kyung-Sook Yang1, Yeon-Seok Seo2, Soon-Ho Um2, Sung-Ock  Suh Division of HBP Surgery and Liver Transplantation, Department of Surgery, Korea University College of Medicine, Seoul,  Departments of 1Biostatistics and 2Internal Medicine, Korea University College of Medicine, Seoul, Korea INTRODUCTION For several decades since Starzl et al.",Non-OADS,/arxiv_data1/oa_pdf/47/30/astr-87-22.PMC4091440.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose: To evaluate patient triage pattern and outcomes according to types of liver transplantation as part of a new liver  transplant program developed in an East Asian country with a limited number of deceased donors.",Non-OADS,/arxiv_data1/oa_pdf/47/30/astr-87-22.PMC4091440.pdf
Available from: http://www.konos.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/47/30/astr-87-22.PMC4091440.pdf
"28pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.28 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Mechanical thromboprophylaxis is sufficient to prevent  the lower extremity deep vein thrombosis after kidney  transplantation Kang-Woong Jun, Keun-Myoung Park, Mi-Hyeong Kim, Jeong-Kye Hwang1, Soon-Chul Park2, In-Sung Moon,  Byung-Ha Chung3, Bum-Soon Choi3, Chul-Woo Yang3, Yong-Soo Kim3, Ji-Il Kim Department of Surgery, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, 1Department of Surgery, The Catholic  University of Korea, Daejeon St. Mary’s Hospital, Daejeon, 2Department of Surgery, The Catholic University of Korea, Uijeongbu  St. Mary’s Hospital, Uijeongbu, 3Department of Internal Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital,  Seoul, Korea INTRODUCTION Deep vein thrombosis (DVT) is a serious medical problem  that can result in complications such as pulmonary embolism,  pulmonary hypertension, and chronic venous insufficiency of  the lower extremities.",Non-OADS,/arxiv_data1/oa_pdf/57/e4/astr-87-28.PMC4091441.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Deep vein thrombosis (DVT) is a severe and common complication that occurs after the major operation.",Non-OADS,/arxiv_data1/oa_pdf/57/e4/astr-87-28.PMC4091441.pdf
" Annals of Surgical Treatment and Research 5pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.5 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Prognosis of early mucinous gastric carcinoma Seong Yeob Ryu, Ho Gun Kim, Jae Hyuk Lee1, Dong Yi Kim Division of Gastroenterologic Surgery, Department of Surgery, Chonnam National University Medical School, Gwangju,  1Department of Pathology, Chonnam National University Medical School, Gwangju, Korea INTRODUCTION Mucinous gastric carcinoma (MGC) is a rare pathological  subtype, comprising 2.4%–10% of all gastric carcinomas [1-4].",Non-OADS,/arxiv_data1/oa_pdf/2c/02/astr-87-5.PMC4091442.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose: Little is known about the clinicopathological features of early mucinous gastric carcinoma (MGC).",Non-OADS,/arxiv_data1/oa_pdf/2c/02/astr-87-5.PMC4091442.pdf
" Annals of Surgical Treatment and Research 47pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.47 Annals of Surgical Treatment and ResearchTECHNICAL ADVANCE The paracholedochal vein: a feasible option as portal  inflow in living donor liver transplantation Joo Dong Kim, Dong Lak Choi, Young Seok Han Division of Hepatobiliary Pancreas Surgery and Abdominal Organ Transplantation, Department of Surgery, Daegu Catholic  University School of Medicine, Daegu, Korea INTRODUCTION Portal vein thrombosis (PVT) with cavernous transformation  of the portal vein (CTPV) represents a surgically demanding  challenge in living donor liver transplantation (LDLT) [1].",Non-OADS,/arxiv_data1/oa_pdf/9f/b8/astr-87-47.PMC4091443.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Extensive thrombosis of the portal and splenomesenteric veins combined with cavernous transformation of the portal vein  (CTPV) has been considered to be a contraindication for living donor liver transplantation (LDLT) due to technical difficulties  and perioperative risks.",Non-OADS,/arxiv_data1/oa_pdf/9f/b8/astr-87-47.PMC4091443.pdf
"14pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.14 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Histopathologic factors affecting tumor recurrence after  hepatic resection in colorectal liver metastases Min-Su Park, Nam-Joon Yi, Sang-Yong Son1, Tae You, Suk-Won Suh, Young Rok Choi, Hyeyoung Kim, Geun  Hong, Kyoung Bun Lee2, Kwang-Woong Lee, Seung-Yong Jeong, Kyu Joo Park, Kyung-Suk Suh, Jae-Gahb  Park Department of Surgery, Seoul National University College of Medicine, Seoul, 1Department of Surgery, Seoul National University  Bundang Hospital, Seongnam, 2Department of Pathology, Seoul National University College of Medicine, Seoul, Korea INTRODUCTION Hepatic resection is a standard method of treatment for  colorectal liver metastases (CRLM).",Non-OADS,/arxiv_data1/oa_pdf/f9/2b/astr-87-14.PMC4091444.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose: Hepatic resection is a standard method of treatment for colorectal liver metastases (CRLM).",Non-OADS,/arxiv_data1/oa_pdf/f9/2b/astr-87-14.PMC4091444.pdf
" Annals of Surgical Treatment and Research 9pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.9 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Multicenter nonrandomized trial of ramosetron versus  palonosetron in controlling chemotherapy-induced  nausea and vomiting for colorectal cancer Jin Soo Kim, Ji Yeon Kim, Sang-Jeon Lee1, Dong Kook Park2, Hwan Namgung2, Chang Nam Kim3, Won Jun  Choi4, Moo Jun Baek5 Department of Surgery, Chungnam National University School of Medicine, Daejeon, 1Department of Surgery, Chungbuk National  University School of Medicine, Cheongju, 2Department of Surgery, Dankook University College of Medicine, Cheonan,  3Department of Surgery, Eulji University School of Medicine, Daejeon, 4Department of Surgery, Konyang University College of  Medicine, Daejeon, 5Department of Surgery, Sooncheonhyang University College of Medicine, Cheonan, Korea INTRODUCTION Chemotherapy-induced nausea and vomiting (CINV) are the  main adverse events during cancer management [1].",Non-OADS,/arxiv_data1/oa_pdf/07/de/astr-87-9.PMC4091445.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Chemotherapy-induced nausea and vomiting (CINV) have a negative impact on patients’ quality of life and  frequently pointed to as a major factor for treatment abandonment.",Non-OADS,/arxiv_data1/oa_pdf/07/de/astr-87-9.PMC4091445.pdf
Available from: http://ctep.cancer.gov/ protocolDevelopment/electronic_applica - tions/ctc.htm.,Non-OADS,/arxiv_data1/oa_pdf/07/de/astr-87-9.PMC4091445.pdf
" Annals of Surgical Treatment and Research 35pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.1.35 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Comparisons between prosthetic vascular graft and  saphenous vein graft in femoro-popliteal bypass Keun-Myoung Park, Young Wook Kim, Shin-Seok Yang, Dong-Ik Kim Division of Vascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea INTRODUCTION Infrainguinalfemoropopliteal bypass (IFPB) grafting to treat  lower limb ischemia is one of the most common procedures  undertaken by vascular surgeons.",Non-OADS,/arxiv_data1/oa_pdf/41/19/astr-87-35.PMC4091446.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Infrainguinalfemoropopliteal bypass (IFPB) is recommended to peripheral arterial disease (PAD) with a long  occlusion of the superficial femoral artery (SFA).",Non-OADS,/arxiv_data1/oa_pdf/41/19/astr-87-35.PMC4091446.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6d/0a/jgenv02p0068.PMC4091447.pdf
This is an open- access  article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4b/d4/jgenv02p0064.PMC4091448.pdf
"jgenomics.com  65  pseudoobscura r3.1 and D. ananassae r1.3 reference g e- nomes and annotations from FlyBase  (http://flybase.org), and modENCODE WB and  reproductive tract RNA -seq data [3] from NCBI   (Ta- ble S1).",OADS,/arxiv_data1/oa_pdf/4b/d4/jgenv02p0064.PMC4091448.pdf
This is an open- access article distr ibuted under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/10/7c/jgenv02p0089.PMC4091449.pdf
"To evaluate the reliability of the pipeline, we  tested Enly on three different 454 reads datasets r e- trieved from either the NCBI short read arc hive d a- tabase (SRA, http://www.ncbi.nlm.nih.gov/sra ),  namely Escherichia coli  KO11 (SRS084754) and Staph y- lococcus aureus 649 (SRS114535), or from a previous  sequencing run on Streptococcus pneumoniae AP200  [12].",Non-OADS,/arxiv_data1/oa_pdf/10/7c/jgenv02p0089.PMC4091449.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/af/jgenv02p0077.PMC4091450.pdf
"OncoImmunology 2014; 3:e27811;http://dx.doi.org/10.4161/onci.27811Combinations of immunostimulatory   antibodies with synergistic effects   against spontaneous cancer aizea Morales-Kastresana1, sara Labiano1, Ines Gütgemann2, and Ignacio Melero1,3,* 1Departamento de Inmunología; Centro de Investigación Médica a plicada (CIM a); universidad de Navarra; Pamplona, s pain;   2Department of Pathology; u niversity of Bonn; Bonn, Germany; 3Departamento de Oncología; Clínica u niversidad de Navarra; Pamplona, s pain Keywords:  B7-H1 (PD-L1), CD137 (4-1BB), immunotherapy, OX40 (CD134), T lymphocytes Abbreviations:  HCC, hepatocellular carcinoma; IFN γ, interferon, γ ; IL-2, interleukin-2; mAb, monoclonal antibody; NK,  natural killer; OVA, ovalbumin; TCR, T-cell receptor; TAA, tumor-associated antigen; TNFRSF, tumor necrosis factor receptor  superfamily; PD-1, programmed cell death 1; CTLA-4, cytotoxic T lymphocyte-associated protein 4 Immunostimulatory monoclonal antibodies can be given in combinations, hence modulating the activity of 2 or  more receptors of the immune system.",Non-OADS,/arxiv_data1/oa_pdf/90/a0/onci-3-e27812.PMC4091451.pdf
Clin Cancer Res 2013; 19:997-1008;  PMID:23460531 ; http://dx.doi.org/10.1158/1078- 0432.CCR-12-22142.,Non-OADS,/arxiv_data1/oa_pdf/90/a0/onci-3-e27812.PMC4091451.pdf
J Immunol  2010 ; 184:5493 - 501; PMID:20400706 ; http://dx.doi.org/10.4049/ jimmunol.09030333.,Non-OADS,/arxiv_data1/oa_pdf/90/a0/onci-3-e27812.PMC4091451.pdf
Nat Med   2006 ; 12:693-8; PMID:16680149 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a0/onci-3-e27812.PMC4091451.pdf
Nature  2012 ;  482:405-9; PMID:22318517 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a0/onci-3-e27812.PMC4091451.pdf
Hepatology  2009 ; 49:471- 81; PMID:19105207 ; http://dx.doi.org/10.1002/ hep.22652 6.,Non-OADS,/arxiv_data1/oa_pdf/90/a0/onci-3-e27812.PMC4091451.pdf
Nat Rev Cancer 2007 ; 7:95-106;  PMID:17251916 ; http://dx.doi.org/10.1038/nrc20517.,Non-OADS,/arxiv_data1/oa_pdf/90/a0/onci-3-e27812.PMC4091451.pdf
Clin Cancer Res 2013 ; 19:5542 ;  PMID:24048329 ; http://dx.doi.org/10.1158/1078- 0432.CCR-13-22349.,Non-OADS,/arxiv_data1/oa_pdf/90/a0/onci-3-e27812.PMC4091451.pdf
Clin Cancer Res 2013 ; 19:1044 -53;  PMID:23460535 ; http://dx.doi.org/10.1158/1078- 0432.CCR-12-2065 10.,Non-OADS,/arxiv_data1/oa_pdf/90/a0/onci-3-e27812.PMC4091451.pdf
A clinical trial  of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis  C. J Hepatol 2013 ; 59:81-8; PMID:23466307 ;  http://dx.doi.org/10.1016/j.jhep.2013.02.022,Non-OADS,/arxiv_data1/oa_pdf/90/a0/onci-3-e27812.PMC4091451.pdf
"OncoImmunology 2014; 3:e28810; http://dx.doi.org/10.4161/onci.28810Functional comparison of single-chain   and two-chain anti-CD3-based bispecific  antibodies in gene immunotherapy applications Marta Compte1,*, Ana Álvarez-Cienfuegos1, Natalia Nuñez-Prado1, Noelia  sa inz-Pastor1, Ana Blanco- to ribio1,  Nuria Pescador1, Laura  sa nz1, and Luis Álvarez-Vallina1,2,* 1Molecular im munology un it; ho spital un iversitario Puerta de hi erro; Madrid, sp ain; 2Cell en gineering Group; Department of en gineering; Aarhus un iversity;   Aarhus, Denmark Keywords:  bispecific antibody, diabody, tandem-scFv, in vivo secretion, gene therapy Abbreviations:  CAR, chimeric antigen receptor; CEA, carcinoembryonic antigen; EMA, European Medicines Agency; EpCAM,  epithelial cell adhesion molecule; EMCV, encephalomyocarditis virus; FcR, Fc receptor; mAb, monoclonal antibody; IRES,  internal ribosomal entry site; PBMCs, peripheral blood mononuclear cells; scFv, single-chain variable fragment; ta-scFv,   tandem scFv; TAA, tumor-associated antigens; TCR/CD3, T-cell antigen receptor/CD3 complex;   VH, immunoglobulin variable heavy chain; VL, immunoglobulin variable light chain Gene therapy to achieve in vivo secretion of recombinant anti-CD3 x anti-tumor bispecific antibodies in cancer  patients is being explored as a strategy to counterbalance rapid renal elimination, thereby sustaining levels of bispecific  antibodies in the therapeutic range.",Non-OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Trends Immunol 2004; 25:85-91; PMID :15102367 ;  http://dx.doi.org/10.1016/j.it.2003.12.001 2.,OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Acta Pharmacol Sin 2005; 26:641-8;  PMID:15916728 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
MAbs 2010; 2:129-36;  PMID:20190561 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
MAbs 2012; 4:4-13;  PMID:22327426 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Cancer Immunol Immunother 2007; 56:1637-44;  PMID:17410361 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Nat Biotechnol 2005; 23:1126-36;  PMID:16151406 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Proc Natl Acad Sci U S A 1995; 92:7021-5; PMID:7624362 ; http://dx.doi.org/10.1073/ pnas.92.15.70219.,OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Science 2008; 321:974-7;  PMID:18703743 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Cancer Res 2009; 69:4941-4;  PMID:19509221 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Biotechnol Genet Eng Rev 2012; 28:147-75;  PMID:22616486 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
J Immunol 2003; 171:1070-7; PMID:12847281 ; http://dx.doi.org/10.4049/ jimmunol.171.2.1070 13.,Non-OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Cancer Gene Ther 2007; 14:380-8;  PMID:17218946 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Stem Cells 2009; 27:753-60; PMID:19096041 ; http://dx.doi.org/10.1634/ stemcells.2008-0831 15.,Non-OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Gene Ther 2010; 17:745-51;  PMID:20336155 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
PLoS One 2009; 4:e5381;  PMID:19401768 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Protein Eng 2000; 13:725-34; PMID:11112512 ; http://dx.doi.org/10.1093/ protein/13.10.725 22.,OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Biochem Biophys Res Commun 2005; 327:999-1005;  PMID:15652494 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
Cancer Immunol Immunother 2009; 58:1761-9; PMID:19259665 ; http://dx.doi.org/10.1007/ s00262-009-0684-9 24.,Non-OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
PLoS One 2009; 4:e7174; PMID:19777065 ;  http://dx.doi.org/10.1371/journal.pone.0007174 ©2014 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/9d/e8/onci-3-e28810.PMC4091452.pdf
"Rare Diseases 2014; 2:e28511; http://dx.doi.org/10.4161/rdis.28511 Addendum to: Guo S, Booten SL, Aghajan M, Hung G, Zhao C, Blomenkamp K, Gattis D, Watt A, Freier SM, Teckman JH, et al.",Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
J Clin Invest 2014; 124:251-61; PMID:24355919 ;  http://dx.doi.org/10.1172/JCI67968,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
"Ongoing natural history studies in children (LOGIC, a longitudi - nal study of genetic causes of intrahepatic cholestasis, NCT00571272) and in adults (http://www.slu.edu/x68167.xml) will hopefully shed light on AATD liver dis - ease prevalence, severity, and progression.",Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Clin Sci (Lond) 2009; 116:837- 50; PMID:19426146 ; http://dx.doi.org/10.1042/ CS20080484 2.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
"Am J Gastroenterol  2008; 103:2136-41, quiz 2142;  PMID:18796107 ;  http://dx.doi.org/10.1111/j.1572-0241.2008.01955.x 3.",Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Respir Med 2011; 105:1129-39;  PMID:21367592 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
COPD 2013; 10(Suppl 1):3-8; PMID:23527532 ; http://dx.doi.org/10.3109/154125 55.2013.771956 6.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Orphanet J Rare Dis  2013; 8:149;  PMID:24063809 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
N Engl J Med 1986; 314:736-9; PMID:3485248 ;  http://dx.doi.org/10.1056/NEJM198603203141202 8.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Nature 1992; 357:605-7; PMID:1608473 ;  http://dx.doi.org/10.1038/357605a0 9.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Hepatology 2005; 42:514-21;  PMID:16044402 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Curr Gastroenterol Rep 2006; 8:14-20; PMID:16510030 ; http://dx.doi.org/10.1007/ s11894-006-0059-8 11.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Ann Hum Genet 1994; 58:305-20; PMID:7864587 ;  http://dx.doi.org/10.1111/j.1469-1809.1994.tb00728.x12.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
J Clin Invest  1989; 83:1183-90;  PMID:2784798 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Science  1988; 242:1409-12;  PMID:3264419 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Nucleic Acids Res 1987; 15:7519- 29; PMID:3498933 ; http://dx.doi.org/10.1093/ nar/15.18.7519 15.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Exp Lung Res 2011; 37:291- 300;  PMID:21574874 ; http://dx.doi.org/10.3109/01 902148.2011.554599 17.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Annu Rev Pharmacol Toxicol  2010; 50:259-93;  PMID:20055705 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
J Clin Invest 2014; 124:251- 61; PMID:24355919 ; http://dx.doi.org/10.1172/ JCI67968 21.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Proc Natl Acad Sci U S A 1985; 82:795-9; PMID:3871944 ; http://dx.doi.org/10.1073/ pnas.82.3.79522.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Hum Genomics  2013; 7:22;  PMID:24172014 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Lancet 2005; 365:2225-36; PMID :15978931 ;  http://dx.doi.org/10.1016/S0140-6736(05)66781-5 24.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Biochim Biophys Acta 2012;  1823:1151-62 ;  PMID:22575681 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Trends Mol Med 2013; PMID:24374162 ;  http://dx.doi.org/10.1016/j.molmed.2013.10.007 26.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Curr Gastroenterol Rep 2014; 16:367;  PMID:24338605 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Clin Gastroenterol Hepatol 2012; 10:1278-83;  PMID:22835581 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
COPD 2013; 10(Suppl 1):35-43; PMID:23527737 ;  http://dx.doi.org/10.3109/15412555.2013.765839 30.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Am J Respir Crit Care Med  2006; 173:1072-7;  PMID:16439713 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Acta Paediatr Scand  1988; 77:847-51;  PMID:2905108 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/6e/rdis-2-e28511.PMC4091453.pdf
Internet 2013. http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/000266/WC500035355.pdf (accessed 21 Aug 2013).,OADS,/arxiv_data1/oa_pdf/62/7e/bmjopen-2014-005122.PMC4091455.pdf
Internet 2006. http://www.nice.org.uk/nicemedia/live/10984/30088/30088.pdf (accessed 21 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/62/7e/bmjopen-2014-005122.PMC4091455.pdf
Internet 2010. http://www.sign.,Non-OADS,/arxiv_data1/oa_pdf/62/7e/bmjopen-2014-005122.PMC4091455.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005612).,Non-OADS,/arxiv_data1/oa_pdf/d5/34/bmjopen-2014-005612.PMC4091456.pdf
Clinicalaudit second pilot public report: National results based on strokepatients admitted to and/or discharged from hospital between April – June 2013. http://www.rcplondon.ac.uk/sites/default/files/ssnap_public_report_2_-_national_level_results_april_-_june_2013_with_appendices.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/d5/34/bmjopen-2014-005612.PMC4091456.pdf
SINAP —latest results; January – December 2012. http://www.rcplondon.ac.uk/resources/ sinap-latest-results 8.,OADS,/arxiv_data1/oa_pdf/d5/34/bmjopen-2014-005612.PMC4091456.pdf
2011. http://www.boehringer-ingelheim.com/news/ news_releases/press_releases/2011/04_november_2011_alteplase.,Non-OADS,/arxiv_data1/oa_pdf/d5/34/bmjopen-2014-005612.PMC4091456.pdf
2013. https://sitsinternational.org/ 38.,Non-OADS,/arxiv_data1/oa_pdf/d5/34/bmjopen-2014-005612.PMC4091456.pdf
http://www.basp.ac.uk/ 41.,Non-OADS,/arxiv_data1/oa_pdf/d5/34/bmjopen-2014-005612.PMC4091456.pdf
http://www.improvement.nhs.,Non-OADS,/arxiv_data1/oa_pdf/d5/34/bmjopen-2014-005612.PMC4091456.pdf
http://www.jrcptb.org.uk/trainingandcert/st3-spr/pages/stroke-medicine.aspx 44.,Non-OADS,/arxiv_data1/oa_pdf/d5/34/bmjopen-2014-005612.PMC4091456.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-004998).,Non-OADS,/arxiv_data1/oa_pdf/54/f5/bmjopen-2014-004998.PMC4091458.pdf
http://www.mhlw.go.jp/stf/shingi/2r9852000001qd1o.html 2.,Non-OADS,/arxiv_data1/oa_pdf/54/f5/bmjopen-2014-004998.PMC4091458.pdf
http://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iryou/zaitaku/index.html 3.,OADS,/arxiv_data1/oa_pdf/54/f5/bmjopen-2014-004998.PMC4091458.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005103).,Non-OADS,/arxiv_data1/oa_pdf/68/82/bmjopen-2014-005103.PMC4091459.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/68/82/bmjopen-2014-005103.PMC4091459.pdf
(http://www.jcqcenter.org).30.,Non-OADS,/arxiv_data1/oa_pdf/68/82/bmjopen-2014-005103.PMC4091459.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 004880).,Non-OADS,/arxiv_data1/oa_pdf/d4/5a/bmjopen-2014-004880.PMC4091460.pdf
"New York, NY, 2001. http://www.datamonitor.com http://www.informabusinessinformation.com/About-Us/ 3.",Non-OADS,/arxiv_data1/oa_pdf/d4/5a/bmjopen-2014-004880.PMC4091460.pdf
http://en.wikipedia.org/wiki/NHS_strategic_health_authority 15.,Non-OADS,/arxiv_data1/oa_pdf/d4/5a/bmjopen-2014-004880.PMC4091460.pdf
"General Medical Council; Report , 2012. http://www.gmc-uk.org/education/national_ summary_reports.asp (accessed Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/b2/d8/bmjopen-2014-005140.PMC4091461.pdf
"General Medical Council; Report , 2013. http://www.gmc-uk.org/ education/surveys.asp (accessed Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/b2/d8/bmjopen-2014-005140.PMC4091461.pdf
Royal College of Obstetricians and Gynaecologists (RCOG) and Royal College of Midwives (RCM).2013. http://www.rcog.org.uk/news/rcogrcm-press-announcement-royal-colleges-jointly-address-issue-undermining-and-bullying-workpl(accessed Nov 2013).Box 2 Suggestions to the General Medical Council (GMC) and Medical School ’s Council on how to address under- graduates ’exposure to bullying and harassment.,Non-OADS,/arxiv_data1/oa_pdf/b2/d8/bmjopen-2014-005140.PMC4091461.pdf
"Association of Surgeons in Training (ASiT), 2013. http://www.asit.org/resources/articles/undermining&bullying (accessed Nov 2013).",Non-OADS,/arxiv_data1/oa_pdf/b2/d8/bmjopen-2014-005140.PMC4091461.pdf
http://www.nhsstaffsurveys.com/Page/ 1006/Latest-Results/2013-Results/ (accessed Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/b2/d8/bmjopen-2014-005140.PMC4091461.pdf
"NIHR Service Delivery and Organisation programme, 2013. http://www.nets.nihr.ac.uk/projects/hsdr/10101201(accessed Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/b2/d8/bmjopen-2014-005140.PMC4091461.pdf
"London: The Stationery Office, 2012. http://www.midstaffspublicinquiry.com/report (accessed Jan 2014).",Non-OADS,/arxiv_data1/oa_pdf/b2/d8/bmjopen-2014-005140.PMC4091461.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005165).,Non-OADS,/arxiv_data1/oa_pdf/74/bb/bmjopen-2014-005165.PMC4091462.pdf
http://www.hscic.,Non-OADS,/arxiv_data1/oa_pdf/74/bb/bmjopen-2014-005165.PMC4091462.pdf
http://www.diabetologists-abcd.org.uk/JBDS/JBDS.htm (accessed 25 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/74/bb/bmjopen-2014-005165.PMC4091462.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005866).,Non-OADS,/arxiv_data1/oa_pdf/fe/9e/bmjopen-2014-005866.PMC4091463.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/9e/bmjopen-2014-005866.PMC4091463.pdf
doi:10.1136/ bmjopen-2014-005668 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005668).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
Office for National Statistics: Mortality statistics: Deaths registered in 2011 (Series DR) Table 5. http://www.ons.gov.uk/ons/publications/ re-reference-tables.html?edition=tcm%3A77 –277727 (accessed 11 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
http://www.hscic.gov.uk/ searchcatalogue?productid=9161&q=title%3a%22Hospital+Episode+Statistics%3a+Admitted+patient+care%22&pubdate=%2c2012&sort=Relevance&size=10&page=1#top (accessed 11 Feb2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
"24th (final) report of the home and leisure accident surveillance system, 2000, 2001 and 2002 data.http://www.hassandlass.org.uk/reports/2000_2002.pdf (accessed 11Feb 2014).",OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
2005. http://www.ons.gov.uk/ons/rel/vsob1/ mortality-statistics--injury-and-poisoning--england-and-wales--series-dh4--discontinued-/no--30 –2007/index.html (accessed 11 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
http://www.hscic.gov.uk/catalogue/PUB02533/ hosp-epis-stat-admi-ext-caus-06 –07-tab.xls (accessed 11 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001140 (accessed 6 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
2010. http://www.nhsconfed.org/Publications/Documents/Implementing_trauma_systems_report.pdf (accessed 28 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
"Focus on Accident & Emergency, December 2013. http://www.hscic.gov.uk/catalogue/PUB13040/acci-emer-focu-on-2013-rep-V2.pdf (accessed 28 Feb2014).",Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
2009. http://lx.iriss.org.uk/sites/default/files/resources/DH_101420.pdf (accessed 28 Feb 2014).,OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
"Community Health Services Forum Briefing;2013, 258 http://www.nhsconfed.org/Publications/Documents/Transforming-local-care.pdf (accessed 28 Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
"The Kings Fund, 2014. http://www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/community-services-nigel-edwards-feb14.pdf(accessed 28 Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
2008. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_085828.pdf(accessed 16 Feb 2014).,OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
2010. http://www.nao.org.uk/ report/major-trauma-care-in-england/ (accessed 16 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
http://www.hscic.gov.uk/catalogue/PUB10394/nhs-staf-2002 –2012-over-rep.pdf (accessed 06 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
http://dx.doi.org/10.1016/S0140 –6736(13) 62631 –8 (accessed 03 Mar 2014).,OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
Implement Sci 2013;8:35. http://www.implementationscience.com/content/8/1/35 30.,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
2012.http://www.england.nhs.uk/nursingvision/ (accessed 11 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
2012. http://www.bbc.co.uk/news/health-20583115 (accessed 28 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
The Telegraph 2012 Jan 09. http://www.telegraph.co.,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
2013. http://royalnursing.3cdn.net/e678a38646d8d670b1_ rdm6bgu19.pdf (accessed 16 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/04/bmjopen-2014-005668.PMC4091464.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004607).,Non-OADS,/arxiv_data1/oa_pdf/18/b0/bmjopen-2013-004607.PMC4091465.pdf
"Zoetermeer: Europe External Policy Advisors (EEPA), 2007. http://www.wsscc.org/resources/resource-publications/menstrual-hygiene-neglected-condition-achievement-several-mdgs (accessed 30 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/18/b0/bmjopen-2013-004607.PMC4091465.pdf
"Pokhara, Nepal: WaterAid, 2008. http://www.wateraid.org/~/media/Publications/menstrual-hygiene-south-asia.pdf (accessed 25 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/18/b0/bmjopen-2013-004607.PMC4091465.pdf
2013. http://hwifc.com/wp-content/uploads/2013/02/Detoxification_Fact_Sheet.pdf (accessed 25 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/18/b0/bmjopen-2013-004607.PMC4091465.pdf
"Plant Signaling & Behavior 2013; 8:e26364;  PMID: 24022272; http://dx.doi.org/10.4161/psb.26364In silico  selection of Arabidopsis thaliana  ecotypes  with enhanced stress tolerance Christian m Prasch and u we Sonnewald* Biochemistry Division; Department Biology; Friedrich- alexander- university Erlangen-Nuernberg; Erlangen, Germany Keywords:  Arabidopsis thaliana , ecotypes, stress-responsive genes, in silico analysis, abiotic stress Climate models predict increased occurrences of combined abiotic and biotic stress.",Non-OADS,/arxiv_data1/oa_pdf/da/f4/psb-8-e26364.PMC4091480.pdf
Annu Rev Plant Biol 2004; 55:141-72;  PMID:15377217 ; http://dx.doi.org/10.1146/ annurev.arplant.55.031903.141605 2.,OADS,/arxiv_data1/oa_pdf/da/f4/psb-8-e26364.PMC4091480.pdf
Plant Physiol 2002; 130:1143-51; PMID:12427981 ; http://dx.doi.org/10.1104/ pp.0068584.,Non-OADS,/arxiv_data1/oa_pdf/da/f4/psb-8-e26364.PMC4091480.pdf
Plant Physiol 2004; 134:1683-96; PMID:15047901 ; http://dx.doi.org/10.1104/ pp.103.033431 5.,Non-OADS,/arxiv_data1/oa_pdf/da/f4/psb-8-e26364.PMC4091480.pdf
Plant Physiol  2013; 161:1783-94;  PMID:23447525 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/f4/psb-8-e26364.PMC4091480.pdf
J Exp Bot 2012; 63:3523-43; PMID:22467407 ;  http://dx.doi.org/10.1093/jxb/ers1007.,OADS,/arxiv_data1/oa_pdf/da/f4/psb-8-e26364.PMC4091480.pdf
Plant Physiol 2013; 162:1849-66; PMID:23753177 ;  http://dx.doi.org/10.1104/pp.113.221044 8.,Non-OADS,/arxiv_data1/oa_pdf/da/f4/psb-8-e26364.PMC4091480.pdf
PLoS One 2007; 2:e718;  PMID:17684564 ; http://dx.doi.org/10.1371/ journal.pone.0000718  Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/da/f4/psb-8-e26364.PMC4091480.pdf
"208  www.e-enm.orgEndocrinol Metab 2014;29:208-209 http://dx.doi.org/10.3803/EnM.2014.29.2.208 pISSN 2093-596X  ·  eISSN 2093-5978Response Diagnostic Whole-Body Scan May Not Be Necessary for  Intermediate-Risk Patients with Differentiated Thyroid  Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation  (Endocrinol Metab  2014;29:33-9, Eon Ju Jeon et al.)",Non-OADS,/arxiv_data1/oa_pdf/ed/e8/enm-29-208.PMC4091483.pdf
"As Prof. Jung mentioned, we feel that a prospective, long- Corresponding author:  Eui Dal Jung Department of Internal Medicine, Catholic University of Daegu School of  Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea Tel: +82-53-650-4098, Fax:  +82-53-651-4009, E-mail:  jed15@cu.ac.kr Copyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/e8/enm-29-208.PMC4091483.pdf
Copyright © 2014 Korean Endocrine Society www.e-enm.org 209Endocrinol Metab 2014;29:208-209 http://dx.doi.org/10.3803/EnM.2014.29.2.208 pISSN 2093-596X  ·  eISSN 2093-5978 term study is needed to further investigate the effect of the  presence of thyroid remnant tissue in diagnostic WBS on re - currence and prognosis.,Non-OADS,/arxiv_data1/oa_pdf/ed/e8/enm-29-208.PMC4091483.pdf
"www.e-enm.org 163Endocrinol Metab 2014;29:163-168 http://dx.doi.org/10.3803/EnM.2014.29.2.163 pISSN 2093-596X  ·  eISSN 2093-5978Original Article Insulin Phosphorylates Tyrosine Residue 464 of Tub and  Translocates Tubby into the Nucleus in HIRcB Cells Jin Wook Kim1, Hyeon Soo Kim2, Sang Dae Kim3, Jung Yul Park4 1Department of Neurosurgery, Gachon University Gil Medical Center, Incheon; 2Department of Anatomy, Korea University  College of Medicine, Seoul; 3Department of Neurosurgery, Korea University Ansan Hospital, Korea University College of  Medicine, Ansan; 4Department of Neurosurgery, Korea University Anam Hospital, Korea University College of Medicine,  Seoul, Korea Background:  The tubby protein has a motif that might be relevant for its action in the insulin signaling pathway.",Non-OADS,/arxiv_data1/oa_pdf/c7/85/enm-29-163.PMC4091484.pdf
"The tubby protein is a member of a homologous family with  four members (tubby and TULP s 1 to 3) encoded in the hu - man genome and with others present in various multicellular  Received:  2 September 2013, Accepted:  17 February 2014 Corresponding author:  Jung Yul Park  Department of Neurosurgery, Korea University Anam Hospital, Korea  University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul   136-705, Korea Tel: +82-2-920-5004, Fax:  +82-2-923-6030, E-mail:  jypark@kumc.or.krCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/85/enm-29-163.PMC4091484.pdf
"144  www.e-enm.orgEndocrinol Metab 2014;29:144-145 http://dx.doi.org/10.3803/EnM.2014.29.2.144 pISSN 2093-596X  ·  eISSN 2093-5978Editorial The Biochemical Prognostic Factors of Subclinical  Hypothyroidism You Jin Lee Center for Thyroid Cancer, National Cancer Center, Goyang, Korea Subclinical hypothyroidism (SCH) is a very common condi - tion and is defined as elevated serum thyroid-stimulating hor - mone (TSH) level with normal levels of circulating free thy - roxine and triiodothyronine [1].",Non-OADS,/arxiv_data1/oa_pdf/65/85/enm-29-144.PMC4091485.pdf
"Garber JR, Cobin RH, Gharib H, Hennessey JV , Klein I,  Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA;  American Association of Clinical Endocrinologists and  American Thyroid Association Taskforce on Hypothyroid - Corresponding author:  You Jin Lee Center for Thyroid Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu,  Goyang 410-769, Korea Tel: +82-31-920-1664, Fax:  +82-31-920-0846, E-mail:  euleemd@gmail.comCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/65/85/enm-29-144.PMC4091485.pdf
The Biochemical Prognostic Factors of Subclinical Hypothyroidism Copyright © 2014 Korean Endocrine Society www.e-enm.org 145Endocrinol Metab 2014;29:144-145 http://dx.doi.org/10.3803/EnM.2014.29.2.144 pISSN 2093-596X  ·  eISSN 2093-5978 ism in Adults.,Non-OADS,/arxiv_data1/oa_pdf/65/85/enm-29-144.PMC4091485.pdf
"www.e-enm.org 105Endocrinol Metab 2014;29:105-111 http://dx.doi.org/10.3803/EnM.2014.29.2.105 pISSN 2093-596X  ·  eISSN 2093-5978Review Article Transcriptional Regulation of Fibroblast Growth Factor 21  Expression Kwi-Hyun Bae, Jung-Guk Kim, Keun-Gyu Park Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyungpook National University School of  Medicine, Daegu, Korea Fibroblast growth factor 21 (FGF21) is an attractive target for treating metabolic disease due to its wide-ranging beneficial effects  on glucose and lipid metabolism.",Non-OADS,/arxiv_data1/oa_pdf/88/01/enm-29-105.PMC4091486.pdf
"The physiologi - cal actions of FGF21 occur at lower concentrations and in  more restricted organ systems and tissues than the pharmaco - Corresponding author:  Keun-Gyu Park Department of Internal Medicine, Kyungpook National University Hospital,  Kyungpook National University School of Medicine, 130 Dongdeok-ro,   Jung-gu, Daegu 700-721, Korea Tel: +82-53-200-3159, Fax:  +82-53-426-6722, E-mail:  kpark@knu.ac.krCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/88/01/enm-29-105.PMC4091486.pdf
"www.e-enm.org 179Endocrinol Metab 2014;29:179-184 http://dx.doi.org/10.3803/EnM.2014.29.2.179 pISSN 2093-596X  ·  eISSN 2093-5978Original Article Gene Expression Regulation by Agonist-Independent  Constitutive Signaling of Melanocortin-1 Receptor Ikjoo Seong, Jaesang Kim Department of Life Science and Ewha Research Center for Systems Biology, Ewha Womans University, Seoul, Korea Background:  Melanocortin-1 receptor (Mc1r), a key signaling receptor for melanogenesis, has been reported to mediate migra - tion of B16F10 melanoma cells.",OADS,/arxiv_data1/oa_pdf/51/d2/enm-29-179.PMC4091487.pdf
"It appears that constitutive  signaling of Mc1r positively regulates expression of several  Received:  31 July 2013, Accepted:  20 February 2014 Corresponding author:  Jaesang Kim Department of Life Science and Ewha Research Center for Systems Biology,  Ewha Womans University, Science Building, 52 Ewhayeodae-gil,   Seodaemun-gu, Seoul 120-750, Korea Tel: +82-2-3277-3414, Fax:  +82-2-3277-3760, E-mail:  jkim1964@ewha.ac.krCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/51/d2/enm-29-179.PMC4091487.pdf
"206  www.e-enm.orgEndocrinol Metab 2014;29:206-207 http://dx.doi.org/10.3803/EnM.2014.29.2.206 pISSN 2093-596X  ·  eISSN 2093-5978Letter Diagnostic Whole-Body Scan May Not Be Necessary for  Intermediate-Risk Patients with Differentiated Thyroid  Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation   (Endocrinol Metab  2014;29:33-9, Eon Ju Jeon et al.)",Non-OADS,/arxiv_data1/oa_pdf/d9/17/enm-29-206.PMC4091488.pdf
"Corresponding author:  Chan-Hee Jung, Division of Endocrinology and Metabolism, Department of Internal Medicine,  Soonchunhyang University College of Medicine, 170 Jomaru-ro, Wonmi-gu,  Bucheon 420-767, Korea Tel: +82-32-621-5158, Fax:  +82-32-621-5016, E-mail:  chanh@schmc.ac.krCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/17/enm-29-206.PMC4091488.pdf
Copyright © 2014 Korean Endocrine Society www.e-enm.org 207Endocrinol Metab 2014;29:206-207 http://dx.doi.org/10.3803/EnM.2014.29.2.206 pISSN 2093-596X  ·  eISSN 2093-5978 CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/d9/17/enm-29-206.PMC4091488.pdf
"www.e-enm.org 169Endocrinol Metab 2014;29:169-178 http://dx.doi.org/10.3803/EnM.2014.29.2.169 pISSN 2093-596X  ·  eISSN 2093-5978Original Article Highly Palatable Food during Adolescence Improves  Anxiety-Like Behaviors and Hypothalamic-Pituitary- Adrenal Axis Dysfunction in Rats that Experienced  Neonatal Maternal Separation Jong-Ho Lee1,2,3, Jin Young Kim1, Jeong Won Jahng3 1Program in Craniofacial Structure and Functional Biology, Department of Dental Science, Graduate School, Seoul National  University School of Dentistry; 2Department of Oral and Maxillofacial Surgery, 3Dental Research Institute, Seoul National  University School of Dentistry, Seoul, Korea Background:  This study was conducted to examine the effects of ad libitum  consumption of highly palatable food (HPF) during  adolescence on the adverse behavioral outcome of neonatal maternal separation.",Non-OADS,/arxiv_data1/oa_pdf/33/1e/enm-29-169.PMC4091489.pdf
"Neo - natal maternal separation is considered an animal model of  Received:  30 July 2013, Accepted:  2 October 2013 Corresponding author:  Jeong Won Jahng Dental Research Institute, Seoul National University School of Dentistry,   101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82-2-2072-0739, Fax:  +82-2-766-4948, E-mail:  jwjahng@snu.ac.krCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/33/1e/enm-29-169.PMC4091489.pdf
"112  www.e-enm.orgEndocrinol Metab 2014;29:112-121 http://dx.doi.org/10.3803/EnM.2014.29.2.112 pISSN 2093-596X  ·  eISSN 2093-5978Review Article Neurocognitive Changes and Their Neural Correlates in  Patients with Type 2 Diabetes Mellitus Junghyun H Lee1,2,*, Yera Choi2,3,*, Chansoo Jun1,2, Young Sun Hong2,4, Han Byul Cho2,3, Jieun E Kim2,5,   In Kyoon Lyoo1,2 1College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University; 2Ewha Brain Institute, Ewha  Womans University; 3Interdisciplinary Program in Neuroscience, Seoul National University College of Natural Sciences;  4Department of Internal Medicine, Ewha Womans University School of Medicine; 5Department of Brain and Cognitive  Sciences, Ewha Womans University Graduate School, Seoul, Korea As the prevalence and life expectancy of type 2 diabetes mellitus (T2DM) continue to increase, the importance of effective detec - tion and intervention for the complications of T2DM, especially neurocognitive complications including cognitive dysfunction  and dementia, is receiving greater attention.",Non-OADS,/arxiv_data1/oa_pdf/58/74/enm-29-112.PMC4091490.pdf
"In the present review, we will discuss the characteristic cogni - tive impairment observed in T2DM and present a summary of  the outcomes from recent neuroimaging studies focusing on  Corresponding author:  In Kyoon Lyoo College of Pharmacy and Graduate School of Pharmaceutical Sciences,   Ewha Brain Institute, Ewha Womans University, Suite #202, Appenzeller  Building, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 120-750, Korea Tel: +82-2-3277-3039, Fax:  +82-2-3277-3044, E-mail:  inkylyoo@ewha.ac.kr *These authors contributed equally to this work.Copyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/58/74/enm-29-112.PMC4091490.pdf
Neurocognitive Changes in Type 2 Diabetes Mellitus Copyright © 2014 Korean Endocrine Society www.e-enm.org 113Endocrinol Metab 2014;29:112-121 http://dx.doi.org/10.3803/EnM.2014.29.2.112 pISSN 2093-596X  ·  eISSN 2093-5978 T2DM-related brain deficits in humans.,Non-OADS,/arxiv_data1/oa_pdf/58/74/enm-29-112.PMC4091490.pdf
"136  www.e-enm.orgEndocrinol Metab 2014;29:136-143 http://dx.doi.org/10.3803/EnM.2014.29.2.136 pISSN 2093-596X  ·  eISSN 2093-5978Review Article Diagnostic Modalities for FGF23-Producing Tumors in  Patients with Tumor-Induced Osteomalacia Seiji Fukumoto Division of Nephrology and Endocrinology, Department of Medicine, University of Tokyo Hospital, Tokyo, Japan Fibroblast growth factor 23 (FGF23) is a hormone that is produced by osteocytes and regulates phosphate and vitamin D metabo - lism through binding to the Klotho-FGF receptor complex.",Non-OADS,/arxiv_data1/oa_pdf/c6/02/enm-29-136.PMC4091491.pdf
"Single injection of re - combinant FGF23 in mice caused reduction in serum phos - Corresponding author:  Seiji Fukumoto Division of Nephrology and Endocrinology, Department of Medicine,  University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan Tel: +81-3-3815-5411, Fax:  +81-3-5800-9836,   E-mail:  fukumoto-tky@umin.ac.jpCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/02/enm-29-136.PMC4091491.pdf
"Localization of Tumors Causing TIO Copyright © 2014 Korean Endocrine Society www.e-enm.org 137Endocrinol Metab 2014;29:136-143 http://dx.doi.org/10.3803/EnM.2014.29.2.136 pISSN 2093-596X  ·  eISSN 2093-5978 phate and 1,25-dihydroxyvitamin D [1,25(OH) 2D] levels [5].",Non-OADS,/arxiv_data1/oa_pdf/c6/02/enm-29-136.PMC4091491.pdf
"www.e-enm.org 185Endocrinol Metab 2014;29:185-194 http://dx.doi.org/10.3803/EnM.2014.29.2.185 pISSN 2093-596X  ·  eISSN 2093-5978Original Article A Novel Cytosolic Isoform of Mitochondrial Trans-2- Enoyl-CoA Reductase Enhances Peroxisome Proliferator- Activated Receptor α Activity Dong-Gyu Kim1, Jae Cheal Yoo1, Eunju Kim2, Young-Sun Lee1, Oleg V .",Non-OADS,/arxiv_data1/oa_pdf/4e/00/enm-29-185.PMC4091492.pdf
"Mito - Received:  13 August 2013, Accepted:  11 October 2013 Corresponding author:  Jae-Yong Park  Department of Physiology, Gyeongsang National University School of  Medicine, 15 Jinju-daero 816beon-gil, Jinju 660-751, Korea Tel: +82-55-772-8043, Fax:  +82-55-772-8049, E-mail:  jaeyong@gnu.ac.krCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/00/enm-29-185.PMC4091492.pdf
"122  www.e-enm.orgEndocrinol Metab 2014;29:122-135 http://dx.doi.org/10.3803/EnM.2014.29.2.122 pISSN 2093-596X  ·  eISSN 2093-5978Review Article Regulation of Adipocyte Differentiation via MicroRNAs You Hwa Son1,*, Sojeong Ka2, A Young Kim2, Jae Bum Kim1,2 1Seoul National University School of Biological Sciences; 2Institute of Molecular Biology and Genetics, Seoul National  University, Seoul, Korea Adipocyte differentiation, termed adipogenesis, is a complicated process in which pluripotent mesenchymal stem cells differenti - ate into mature adipocytes.",Non-OADS,/arxiv_data1/oa_pdf/63/ae/enm-29-122.PMC4091493.pdf
"Corresponding author:  Jae Bum Kim School of Biological Sciences and Institute of Molecular Biology and Genetics,  Seoul National University,1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea Tel: +82-2-880-5852, Fax:  +82-2-878-5852, E-mail:  jaebkim@snu.ac.kr *Current affiliation: Division of Drug Discovery Research, Pharmacological  Research Center, Korea Research Institute of Chemical Technology,   Daejeon, KoreaCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/63/ae/enm-29-122.PMC4091493.pdf
"Roles of MicroRNAs in Adipogenesis Copyright © 2014 Korean Endocrine Society www.e-enm.org 123Endocrinol Metab 2014;29:122-135 http://dx.doi.org/10.3803/EnM.2014.29.2.122 pISSN 2093-596X  ·  eISSN 2093-5978 MOLECULAR EVENTS DURING  ADIPOCYTE DIFFERENTIATION  In vitro  studies have suggested that the progression of adipo - cyte differentiation has, at least, two key steps: commitment  and differentiation.",Non-OADS,/arxiv_data1/oa_pdf/63/ae/enm-29-122.PMC4091493.pdf
"146  www.e-enm.orgEndocrinol Metab 2014;29:146-153 http://dx.doi.org/10.3803/EnM.2014.29.2.146 pISSN 2093-596X  ·  eISSN 2093-5978Original Article Genetic Analysis of Multiple Endocrine Neoplasia Type 1  (MEN1 ) Leads to Misdiagnosis of an Extremely Rare  Presentation of Intrasellar Cavernous Hemangioma as  MEN1 Dong Min Lee, Seung Hee Yu, Hyun Hwa Yoon, Kang Lock Lee, Young Sil Eom, Kiyoung Lee, Byung-Joon Kim,  Yeun Sun Kim, Ie Byung Park, Kwang-Won Kim, Sihoon Lee Division of Endocrinology and Metabolism, Department of Internal Medicine, Gachon Univeristy School of Medicine, Incheon,  Korea Background:  Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited disorder characterized by the simultaneous occur - rence of endocrine tumors in target tissues (mainly the pituitary, endocrine pancreas, and parathyroid glands).",Non-OADS,/arxiv_data1/oa_pdf/13/df/enm-29-146.PMC4091494.pdf
"Keywords: Multiple endocrine neoplasia type 1; MEN1  gene; Intrasellar cavernous hemangioma Received:  13 March 2013, Accepted:  1 October 2013 Corresponding author:  Sihoon Lee   Department of Internal Medicine, Laboratory of Genomic and Translational  Medicine, Gachon University School of Medicine, 21 Namdong-daero 774  beon-gil, Namdong-gu, Incheon 405-760, Korea Tel: +82-32-460-8207, Fax:  +82-32-460-3009, E-mail:  shleemd@gachon.ac.krCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/13/df/enm-29-146.PMC4091494.pdf
"Intrasellar Cavernous Hemangioma with Accompanying Pancreatic Lesion Copyright © 2014 Korean Endocrine Society www.e-enm.org 147Endocrinol Metab 2014;29:146-153 http://dx.doi.org/10.3803/EnM.2014.29.2.146 pISSN 2093-596X  ·  eISSN 2093-5978 INTRODUCTION Multiple endocrine neoplasia type 1 (MEN1) is an autosomal  dominant genetic disease involving more than two tumors oc - curring simultaneously among the pituitary, islet cell, and  parathyroid gland.",Non-OADS,/arxiv_data1/oa_pdf/13/df/enm-29-146.PMC4091494.pdf
"In direct sequencing, forward and  reverse sequencing analysis were conducted for each primer to  reduce analysis errors, and mutation and polymorphism were  identified by comparing the DNA sequencing results to data  on dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/).",OADS,/arxiv_data1/oa_pdf/13/df/enm-29-146.PMC4091494.pdf
"www.e-enm.org 195Endocrinol Metab 2014;29:195-201 http://dx.doi.org/10.3803/EnM.2014.29.2.195 pISSN 2093-596X  ·  eISSN 2093-5978Case Report A Novel PHEX  Gene Mutation in a Patient with Sporadic  Hypophosphatemic Rickets Yea Eun Kang1, Jun Hwa Hong2, Jimin Kim1, Kyong Hye Joung1, Hyun Jin Kim1, Bon Jeong Ku1, Koon Soon Kim1 1Research Center for Endocrine and Metabolic Diseases, Department of Internal Medicine, Chungnam National University  School of Medicine, Daejeon; 2Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea Phosphate regulating gene with homologies to endopeptidases on the X-chromosome (PHEX) is a common cause of X-linked  hypophosphatemic (XLH) rickets.",Non-OADS,/arxiv_data1/oa_pdf/da/ec/enm-29-195.PMC4091495.pdf
"Received:  19 April 2013, Accepted:  27 June 2013 Corresponding author:  Koon Soon Kim Research Center for Endocrine and Metabolic Diseases, Department of Internal  Medicine, Chungnam National University Hospital, Chungnam National  University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 301-721,  Korea Tel: +82-42-280-7134, Fax:  +82-42-280-7995, E-mail:  kunsunkim@naver.comCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/da/ec/enm-29-195.PMC4091495.pdf
Sequences of Primers for Polymerase Chain Reaction Sense (5’-to-3’) Antisense (5’-to-3’) Exon1 ttagtagaagagcaagaaagcc ctgtgttatgacaagttttgct Exon2 tcaaatatcttgcgtatgtttc tcaaaattgcatttcgtactt Exon3 ttgttgtttaatttggaaaaga gcatggtagttaaaaagtgaga Exon4 ggaggttggaattgtgattat gaattcttagtagttctcttcttcct Exon5 gcacttaaattctagtgtgctg tatttcactaaggcagcatga Exon6 atggtgacatgagctcaaaata acactgctcatttccaataaa Exon7 ctacctgctattttctgctctt tcattcaggatatactgccttt Exon8 aatactatgcagatgttttggc caagactgagagcaggttttac Exon9 tgaaatcaaaagaaatgaatga agttttcaaaggatgtgagaag Exon10 ctgtttctctcaagatgttctg ccctgtctaatccctaaagatg Exon11 agactgttttcttcaggttgtt acaatacccacaggccactac Exon12 taaagagtcatttctcatgcaa tatgtattcatccaaaagcaga Exon13 ttcagtaaatggagttttcagat atcaccagttttaattgctagg Exon14 ccttcctatgctgaagtatttt tactctgacttgaggggaatta Exon15 cattgttccatgttatctgcta aatgtcttaccctccatcatag Exon16 ggtctttgaaacctcagtgtta ttctttctgctgaataaccttt Exon17 ctagaaagcagtttatcttggc atcttcaagctatgatgctgc Exon18 ctgttatgactgctttttgaag acagatgctgttgatcttgtaa Exon19 ttgctataatattgatgcctctt ttccataatatctaactaactaactcc Exon20 cgtggcaggagtatatatttg tttgtttgaaatctttctttga Exon21 ggttctaaaattgttcctcagt tttttcagatcacctatctggt Exon22–23 agcaatattctgctacagtttt gtctccaggcctaaagcaat Primers were designed with primer 3 web version 4.0 served from  Whitehead Institute (http://primer3.wi.mit.edu/) using sequences from  GenBank accession number of NT_167197.1.,Non-OADS,/arxiv_data1/oa_pdf/da/ec/enm-29-195.PMC4091495.pdf
"202  www.e-enm.orgEndocrinol Metab 2014;29:202-205 http://dx.doi.org/10.3803/EnM.2014.29.2.202 pISSN 2093-596X  ·  eISSN 2093-5978Case Report Recurrent Hypoglycemia Triggered by Sorafenib Therapy  in a Patient with Hemangiopericytoma Si Won Lee1, Eun Kyung Lee1, Tak Yun1, Young-Woong Won1,*, Eun Jeong Ko1, Mihong Choi1, Sang Il Choi1, Sun Seob Park1,  Eun Kyung Hong2 Departments of 1Internal Medicine, 2Pathology, National Cancer Center, Goyang, Korea Targeted therapy has been proven to be one of the most effective cancer treatments.",Non-OADS,/arxiv_data1/oa_pdf/e4/40/enm-29-202.PMC4091496.pdf
"In August 2009,  Received:  15 April 2013, Accepted:  27 June 2013 Corresponding author:  Eun Kyung Lee Department of Internal Medicine, National Cancer Center, 323 Ilsan-ro,  Ilsandong-gu, Goyang 410-769, Korea Tel: +82-31-920-1743, Fax:  +82-31-920-2798, E-mail:  waterfol@gmail.com *  Current affiliation: Center for Clinical Trials, National Cancer Center, Goyang  and Division of Hematology and Oncology, Department of Internal Medicine,  Hanyang University Guri Hospital, Hanyang University College of Medicine,  Guri, KoreaCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/40/enm-29-202.PMC4091496.pdf
HPC-Associated Hypoglycemia Triggered by Sorafenib  Copyright © 2014 Korean Endocrine Society www.e-enm.org 203Endocrinol Metab 2014;29:202-205 http://dx.doi.org/10.3803/EnM.2014.29.2.202 pISSN 2093-596X  ·  eISSN 2093-5978 she experienced a recurrent mass at the same site with multiple  hepatic metastases.,Non-OADS,/arxiv_data1/oa_pdf/e4/40/enm-29-202.PMC4091496.pdf
"154  www.e-enm.orgEndocrinol Metab 2014;29:154-162 http://dx.doi.org/10.3803/EnM.2014.29.2.154 pISSN 2093-596X  ·  eISSN 2093-5978Original Article The Biochemical Prognostic Factors of Subclinical  Hypothyroidism Myung Won Lee, Dong Yeob Shin, Kwang Joon Kim, Sena Hwang, Eun Jig Lee Division of Endocrinology, Department of Internal Medicine, Institute of Endocrine Research, Yonsei University College of  Medicine, Seoul, Korea Background:  Patients with subclinical hypothyroidism (SHT) are common in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/99/d1/enm-29-154.PMC4091497.pdf
"As a result, concerns about the natural course  Received:  25 April 2013, Accepted:  13 October 2013 Corresponding author:  Eun Jig Lee Division of Endocrinology, Department of Internal Medicine, Yonsei University  College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: +82-2-2228-5003, Fax:  +82-2-393-6884, E-mail:  ejlee423@yuhs.acCopyright © 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/99/d1/enm-29-154.PMC4091497.pdf
The Biochemical Prognostic Factors of Subclinical Hypothyroidism Copyright © 2014 Korean Endocrine Society www.e-enm.org 155Endocrinol Metab 2014;29:154-162 http://dx.doi.org/10.3803/EnM.2014.29.2.154 pISSN 2093-596X  ·  eISSN 2093-5978 and prognosis of SHT and long-term consequences of a persis - tent subclinical hypothyroid state are on the rise.,Non-OADS,/arxiv_data1/oa_pdf/99/d1/enm-29-154.PMC4091497.pdf
"However, our recent findings and  work from other groups demonstrates  that missense mutations in the gene that  encodes SHP-1 ( Ptpn6 ) promotes the  development of an inflammatory skin  disease in mice that closely resembles  neutrophilic dermatosis in humans.4,5 SHP-1 is a protein tyrosine  phosphatase that has been described to  function as a negative regulator of signal  transduction in a variety of cell types.6- 10 Alterations in SHP-1 activity have  been linked to multiple human diseases  including leukemia, psoriatic arthritis,  and multiple sclerosis.11-15 In addition,  pivotal roles for SHP-1 in the regulation of  autoinflammatory disease came from the SHP-1 and IL-1 α conspire to provoke neutrophilic dermatoses John R Lukens and Thirumala-Devi Kanneganti * Department of Immunology; St. Jude Children’s Research Hospital; Memphis, TN USA Keywords:  neutrophilic dermatosis, SHP- 1, Ptpn6, inflammasome, NOD-like  receptor, caspase-1, interleukin, RIP1,  RIP3, inflammation Abbreviations:  IL, interleukin; Nec-1,  necrostatin-1; NLR, NOD-like receptor;  RIP, Receptor-Interacting Protein; SH2,  Src Homology 2; SHP-1, SH2 domain- containing phosphatase-1; CAPS,  cryopyrin-associated periodic syndromes;  PAMPs, pathogen-associated molecular  patterns; and DAMPs, danger-associated  molecular patterns *Correspondence to: Thirumala-Devi Kanneganti;  Email: Thirumala-Devi.Kanneganti@StJude.org Submitted: 10/14/2013; Revised:  12/16/2013; Accepted: 01/06/2014;  Published Online: 01/31/2014 http://dx.doi.org/10.4161/rdis.27742 Addendum to: Lukens  JR, Vogel  P, Johnson  GR,  Kelliher  MA, Iwakura  Y, Lamkanfi  M, Kanneganti   TD.",Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Nature   2013 ; 498:224-7; PMID:23708968 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Pediatr Dermatol 2008; 25:509- 19; PMID:18950391 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Curr Opin Hematol   2013 ; 20:26-35; PMID:23207661 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Am J Clin Dermatol   2009 ; 10:301-12; PMID:19658442 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Nature  2013 ; 498:224- 7; PMID:23708968 ; http://dx.doi.org/10.1038/ nature12174 5.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Semin Immunol  2000 ; 12:361- 78; PMID:10995583 ; http://dx.doi.org/10.1006/ smim.2000.0223 7.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
J Exp Med  2013 ; 210:1419 - 31; PMID:23797092 ; http://dx.doi.org/10.1084/ jem.20122239 9.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Annu Rev Immunol  2007 ;  25:473-523; PMID:17291189 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Blood  2012 ; 119:4419 -29;  PMID:22438258 ; http://dx.doi.org/10.1182/ blood-2011-09-377069 11.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
J Hum Genet  2002 ; 47:445- 7; PMID:12181644 ; http://dx.doi.org/10.1007/ s100380200062 12.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Lab Invest  2008 ; 88:243-55; PMID:18209728 ;  http://dx.doi.org/10.1038/labinvest.3700720 13.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Leukemia   2011 ; 25:1768 -81; PMID:21701493 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Gene   2003 ; 306:1-12; PMID:12657462 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
J Invest  Dermatol  2010 ; 130:1590 -7; PMID:20130595 ;  http://dx.doi.org/10.1038/jid.2010.6 16.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Cell  1993 ; 73:1445 -54; PMID:8324828 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Nat  Genet  1993 ; 4:124-9; PMID:8348149 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Am J Pathol  2011 ;  178:1434 -41; PMID:21406173 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Immunity  2013 ; 38:489-501; PMID:23521885 ;  http://dx.doi.org/10.1016/j.immuni.2013.02.018 23.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Nat Rev Immunol   2010 ; 10:688-98; PMID:20847744 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Nat Immunol  2012 ; 13:707- 12; PMID:22814340 ; http://dx.doi.org/10.1038/ ni.2343 27.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Nat Med  2007 ; 13:851-6; PMID:17572686 ;  http://dx.doi.org/10.1038/nm1603 28.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Proc Natl Acad Sci U S A   2010 ; 107:2574 -9; PMID:20133797 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Nat Rev Immunol  2005 ; 5:629- 40; PMID:16034365 ; http://dx.doi.org/10.1038/ nri1664 30.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Nat Immunol  2013 ; 14:1045 - 53; PMID:23995233 ; http://dx.doi.org/10.1038/ ni.2704 32.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Blood  2011 ;  117:3720 -32; PMID:21304099 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Nature   2011 ; 471:363-7; PMID:21368763 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Nature  2011 ; 471:368- 72; PMID:21368762 ; http://dx.doi.org/10.1038/ nature0985735.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Cell Rep  2012 ; 1:401-7;  PMID:22675671 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Proc Natl Acad Sci U S A   2009 ; 106:17031 -6; PMID:19805069 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
J Immunol  2013 ; 190:6329 -39; PMID:23686480 ;  http://dx.doi.org/10.4049/jimmunol.1300100 38.,Non-OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
N Engl J Med  2007 ; 356:1517- 26; PMID:17429083 ; http://dx.doi.org/10.1056/ NEJMoa065213 40.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Proc Natl Acad Sci U S A  2013 ; 110:E3109 -18;  PMID:23898178 ; http://dx.doi.org/10.1073/ pnas.1301218110 41.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Sci Signal  2010 ;  3:re4; PMID:20354226 ; http://dx.doi.org/10.1126/ scisignal.3115re4 42.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
Immunity   1998 ; 8:297-303; PMID:9529147 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/a8/rdis-2-e27742.PMC4091500.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005648).,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/bmjopen-2014-005648.PMC4091503.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/bmjopen-2014-005648.PMC4091503.pdf
"Perth, WA, Australia: Health Department, Government of Western Australia (AU), 2013 [updated June, 2013;cited 2013 Oct 30]; http://www.health.wa.gov.au/anaphylaxis/HP/ 30.",Non-OADS,/arxiv_data1/oa_pdf/4d/5e/bmjopen-2014-005648.PMC4091503.pdf
http://www.randomizer.org 31.,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/bmjopen-2014-005648.PMC4091503.pdf
http://www.allergy.org.au/content/view/10/3/ 32.,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/bmjopen-2014-005648.PMC4091503.pdf
https://http://www.psa.org.au/supporting-practice/professional-practice-standards/version-4 33.,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/bmjopen-2014-005648.PMC4091503.pdf
https://http://www.psa.org.au/supporting-practice/national-competency-standards 34.,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/bmjopen-2014-005648.PMC4091503.pdf
"Nashville, TN: Vanderbilt University School of Medicine, 2009 [updated September 2013; cited 2013 Sep 20];http://biostat.mc.vanderbilt.edu/wiki/Main/PowerSampleSize 35.",Non-OADS,/arxiv_data1/oa_pdf/4d/5e/bmjopen-2014-005648.PMC4091503.pdf
http://www.scotsman.com/news/health/pharmacies-to-offer-allergic-reaction-treatment-1-3038842 66.,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/bmjopen-2014-005648.PMC4091503.pdf
"http://www.communitypharmacyscotland.org.uk/news,-policy-and- publications/policy/anaphylaxis-campaign/anaphylaxis-campaign/ 10 Salter SM, et al.BMJ Open 2014; 4:e005648.",Non-OADS,/arxiv_data1/oa_pdf/4d/5e/bmjopen-2014-005648.PMC4091503.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005092).,Non-OADS,/arxiv_data1/oa_pdf/fc/0f/bmjopen-2014-005092.PMC4091504.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005070).,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/bmjopen-2014-005070.PMC4091505.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/c0/bmjopen-2014-005070.PMC4091505.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005248).,Non-OADS,/arxiv_data1/oa_pdf/fe/83/bmjopen-2014-005248.PMC4091506.pdf
Version No:3. http://php.nhs.uk/wp-content/uploads/sites/26/2013/11/PHP-Three-Year-Report-Final-Version-3.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/fe/83/bmjopen-2014-005248.PMC4091506.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.bs200.,OADS,/arxiv_data1/oa_pdf/0b/fe/bmjopen-2014-005475.PMC4091507.pdf
"Secondary Australian health survey: first results, 2011 –2012 [Website] 7 June 2013. http://www.abs.gov.au/ausstats/ abs@.nsf/Lookup/4364.0.55.001main+features12011-12 3.",Non-OADS,/arxiv_data1/oa_pdf/0b/fe/bmjopen-2014-005475.PMC4091507.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005043).,Non-OADS,/arxiv_data1/oa_pdf/c9/ad/bmjopen-2014-005043.PMC4091508.pdf
"Switzerland: World Health Organization, 2008. http://www.who.int/ violence_injury_prevention/child/injury/world_report/en/ (accessed19 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/c9/ad/bmjopen-2014-005043.PMC4091508.pdf
http://www.aihw.gov.au/publication-detail/?id=6442467501(accessed 4 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/c9/ad/bmjopen-2014-005043.PMC4091508.pdf
"Canberra: Australian Institute of Health and Welfare, 1999. http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id6442459196 (accessed 19 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/c9/ad/bmjopen-2014-005043.PMC4091508.pdf
http://docs.health.vic.gov.au/docs/doc/Victorian-Burden-of-Disease-Study:-Morbidity (accessed 19 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/c9/ad/bmjopen-2014-005043.PMC4091508.pdf
"Hospital Reference Manual Round 11 (2006 –2007), 2007. http://www.health.gov.au/internet/main/ publishing.nsf/Content/health-casemix-data-collections-about(accessed 11 Nov 2012).15.",Non-OADS,/arxiv_data1/oa_pdf/c9/ad/bmjopen-2014-005043.PMC4091508.pdf
http://www.abs.gov.au/Ausstats/abs@.nsf/mf/3218.0(accessed 8 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/c9/ad/bmjopen-2014-005043.PMC4091508.pdf
"Melbourne, Australia: National Public Health Partnership, 2004. http://www.nphp.gov.au/publications/documents/gaa_2_body_ver1.pdf (accessed 8 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/c9/ad/bmjopen-2014-005043.PMC4091508.pdf
"Hazard, Victorian Injury Surveillance Unit 2012; Edn 74. http://www.monash.edu.au/miri/research/ research-areas/home-sport-and-leisure-safety/visu/hazard/haz74.pdf(accessed 3 Jun 2013).",Non-OADS,/arxiv_data1/oa_pdf/c9/ad/bmjopen-2014-005043.PMC4091508.pdf
doi:10.1136/ bmjopen-2014-004916 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-004916).,Non-OADS,/arxiv_data1/oa_pdf/f3/4a/bmjopen-2014-004916.PMC4091509.pdf
2012. http://www.epha.org/IMG/pdf/EPHA_Briefing_EWTD_Oct2012_FINAL.pdf (accessed 2012).,Non-OADS,/arxiv_data1/oa_pdf/f3/4a/bmjopen-2014-004916.PMC4091509.pdf
2013. http://ec.europa.eu/social/main.jsp?catId=706&langId=en&intPageId=205 (accessed Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/f3/4a/bmjopen-2014-004916.PMC4091509.pdf
2011. http://www.drfosterhealth.co.uk (accessed Feb 2011).,Non-OADS,/arxiv_data1/oa_pdf/f3/4a/bmjopen-2014-004916.PMC4091509.pdf
"UEMS Section ofOccupational Medicine, 2011. http://www.uems-occupationalmedicine.",Non-OADS,/arxiv_data1/oa_pdf/f3/4a/bmjopen-2014-004916.PMC4091509.pdf
2010. http://www.uems.eu/__data/assets/pdf_file/0014/1463/1466.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/f3/4a/bmjopen-2014-004916.PMC4091509.pdf
"http://www.uems.eu/__data/assets/pdf_file/0011/1235/UEMS_2011.37_-_report_-_UEMS_Council_6-8.10.2010_Napoli.pdf, ed.",Non-OADS,/arxiv_data1/oa_pdf/f3/4a/bmjopen-2014-004916.PMC4091509.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/f3/4a/bmjopen-2014-004916.PMC4091509.pdf
http://bma.org.uk/ practical-support-at-work/ewtd (accessed Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/f3/4a/bmjopen-2014-004916.PMC4091509.pdf
"3208, MEDICAL PROFESSION,The European Specialist Medical Qualifications Order 1995. http://legislation.data.gov.uk/uksi/1995/3208/made/data.htm?wrap=true(accessed Dec 2013).",Non-OADS,/arxiv_data1/oa_pdf/f3/4a/bmjopen-2014-004916.PMC4091509.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005077).,Non-OADS,/arxiv_data1/oa_pdf/b7/ca/bmjopen-2014-005077.PMC4091510.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/ca/bmjopen-2014-005077.PMC4091510.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005066).,Non-OADS,/arxiv_data1/oa_pdf/1e/90/bmjopen-2014-005066.PMC4091511.pdf
15. http://www.nccmerp.org/medErrorCatIndex.html (accessed 25 May 2014).,OADS,/arxiv_data1/oa_pdf/1e/90/bmjopen-2014-005066.PMC4091511.pdf
National Patient Safety Agency 2009. http://www.nrls.npsa.nhs.uk/resources/?entryid45=59864 (accessed 25 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/1e/90/bmjopen-2014-005066.PMC4091511.pdf
Report of the Mid Staffordshire NHS Foundation Trust Public Enquiry Feb 2013.http://www.midstaffspublicinquiry.com/report.,Non-OADS,/arxiv_data1/oa_pdf/1e/90/bmjopen-2014-005066.PMC4091511.pdf
2013. https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file/226703/Berwick_Report.pdf(accessed 25 May 2014).,OADS,/arxiv_data1/oa_pdf/1e/90/bmjopen-2014-005066.PMC4091511.pdf
2011: Section5.6:92. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213713/dh_131721.pdf(accessed 25 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/1e/90/bmjopen-2014-005066.PMC4091511.pdf
To view please visit the journal(http://dx.doi.org/10.1136/ bmjopen-2014-005028).,Non-OADS,/arxiv_data1/oa_pdf/be/e9/bmjopen-2014-005028.PMC4091513.pdf
"OncoImmunology 2014; 3:e28861; http://dx.doi.org/10.4161/onci.28861Immunosurveillance markers may predict patients  who can discontinue imatinib therapy   without relapse ta kayuki Yoshimoto1,*, izu ru Mizoguchi1, se iichiro Katagiri2, te tsuzo  ta uchi2, Jun-ichi Furusawa1, Yukino Chiba1,3,  Junichiro Mizuguchi3, Junko  h oh yashiki4, and Kazuma  oh yashiki2 1Department of imm unoregulation; in stitute of Medical sc ience; to kyo Medical un iversity; to kyo, Japan; 2Department of he matology; to kyo Medical un iversity; to kyo, Japan;  3Department of im munology; to kyo Medical un iversity; to kyo, Japan; 4Department of Molecular on cology; in stitute of Medical sc ience; to kyo Medical un iversity;   to kyo, Japan Keywords:  chronic myeloid leukemia, imatinib, NK cells, cytotoxic T lymphocytes, predictive marker, immunosurvelliance Abbreviations : CML, chronic myeloid leukemia; CMR, complete molecular response; CTL, cytotoxic lymphocyte; IFN,  interferon; NK, natural killer; TKI, tyrosine kinase inhibitor ty rosine kinase inhibitors have dramatically improved the treatment of chronic myeloid leukemia.",Non-OADS,/arxiv_data1/oa_pdf/8b/cf/onci-3-e28861.PMC4091524.pdf
Nat Med 1996; 2:561-6;  PMID:8616716 ; http://dx.doi.org/10.1038/ nm0596-5613.,Non-OADS,/arxiv_data1/oa_pdf/8b/cf/onci-3-e28861.PMC4091524.pdf
Lancet Oncol 2010; 11:1029-35; PMID:20965785 ; http://dx.doi.org/10.1016/ S1470-2045(10)70233-3 4.,Non-OADS,/arxiv_data1/oa_pdf/8b/cf/onci-3-e28861.PMC4091524.pdf
Haematologica 2012; 97:903-6;  PMID:22180435 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/cf/onci-3-e28861.PMC4091524.pdf
Leukemia 2010; 24:1719-24;  PMID:20811403 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/cf/onci-3-e28861.PMC4091524.pdf
Br J Haematol 2012; 157:254-6; PMID:22077498 ;  http://dx.doi.org/10.1111/j.1365-2141.2011.08939.x 7.,Non-OADS,/arxiv_data1/oa_pdf/8b/cf/onci-3-e28861.PMC4091524.pdf
Cancer Sci 2013; 104:1146-53;  PMID:23758044 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/cf/onci-3-e28861.PMC4091524.pdf
PLoS One 2011; 6:e23022; PMID:21857985 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/8b/cf/onci-3-e28861.PMC4091524.pdf
J Clin Oncol 2010; 28:1429-35; PMID:20142590 ; http://dx.doi.org/10.1200/ JCO.2009.25.5075,Non-OADS,/arxiv_data1/oa_pdf/8b/cf/onci-3-e28861.PMC4091524.pdf
The  standardized nomenclature presented in this document and additional colour images are also available electronically at http://www.goreni.,Non-OADS,/arxiv_data1/oa_pdf/ff/3b/tox-26-S027.PMC4091526.pdf
e-mail: lm@mecklenburg-consulting.de ©2013 The Japanese Society of Toxicologic PathologyThis is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ff/3b/tox-26-S027.PMC4091526.pdf
The standardized nomenclature of lesions presented in this document is also available electroni - cally on the Internet (http://www.goreni.org/).,Non-OADS,/arxiv_data1/oa_pdf/09/4d/tox-26-S001.PMC4091527.pdf
e-mail: pg29@le.ac.uk ©2013 The Japanese Society of Toxicologic PathologyThis is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/09/4d/tox-26-S001.PMC4091527.pdf
Plant  Signaling & Behavior 2014; 9:e27940; PMID: 24492391; http://dx.doi.org/10.4161/psb.27940Pyramiding resistances based on translation  initiation factors in Arabidopsis  is impaired   by male gametophyte lethality Caroline Callot and Jean-Luc Gallois* inra -ur1052; Genetics and Breeding of Fruits and Vegetables; Dom.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Trends Biochem Sci  2010; 35:63-73;  PMID:19926289 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Plant Mol Biol   2010 ; 74:249-63; PMID:20694742 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Trends Plant Sci  2006 ; 11:40-5; PMID:16343979 ;  http://dx.doi.org/10.1016/j.tplants.2005.11.004 7.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
J Biol  Chem  1998 ; 273:10325 -30; PMID:9553087 ;  http://dx.doi.org/10.1074/jbc.273.17.10325 8.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
J Virol   2004 ; 78:6102 -11; PMID:15163703 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
PLoS One  2011 ; 6:e29595 ;  PMID:22242134 ; http://dx.doi.org/10.1371/ journal.pone.0029595 12.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Plant Mol Biol   2005 ; 57:749-60; PMID:15988567 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Mol Plant Pathol  2012 ;  13:795-803; PMID:22379950 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
FEBS Lett  2005 ; 579:1167 -71; PMID:15710407 ;  http://dx.doi.org/10.1016/j.febslet.2004.12.086 15.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
J Gen Virol  2010 ; 91:288-93;  PMID:19741065 ; http://dx.doi.org/10.1099/ vir.0.015321-0 16.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Mol Plant Microbe Interact  2013 ; 26:257- 65; PMID:23013438 ; http://dx.doi.org/10.1094/ MPMI-07-12-0174-R 17.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Int J Dev Biol  2005 ;  49:595-614; PMID:16096968 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Mol Gen Genet  1998 ; 260:444- 52; PMID:9894914 ; http://dx.doi.org/10.1007/ s004380050915 20.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Plant Cell  2009 ; 21:442- 59; PMID:19223514 ; http://dx.doi.org/10.1105/ tpc.108.062372 21.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Genome Biol  2004 ; 5:R85; PMID :15535861 ;  http://dx.doi.org/10.1186/gb-2004-5-11-r85 22.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
Mol Cell Proteomics  2007 ; 6:207-30;  PMID:17132620 ; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
PLoS One   2010 ; 5:e11313 ; PMID:20593023 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/d3/psb-9-e27940.PMC4091535.pdf
"OncoImmunology 2014; 3:e28837; http://dx.doi.org/10.4161/onci.28837Epigenetic remodeling combined   with photodynamic therapy elicits anticancer  immune responses Malgorzata  wac howska1, Magdalena Gabrysiak1, and Jakub Golab1,2,* 1Department of im munology; Center for Biostructure re search; Medical un iversity of wa rsaw; wa rsaw, Poland; 2in stitute of Physical Chemistry; Polish Academy of sc iences;  war saw, Poland Keywords:  photodynamic therapy, 5-aza-2’-deoxycitidine, tumor-associated antigens, cancer, tumor immunology,  methyltransferase, epigenetic Abbreviations:  5-aza-dC, 5-aza-2’-deoxycitidine; CTL, cytotoxic T cells; DAMP, damage-associated molecular pattern; DC,  dendritic cell; IL, interleukin; MHC, major histocompatibility complex; PDT, photodynamic therapy; PS, photosensitizer; TAA,  tumor-associated antigens; TNF, tumor necrosis factor Photodynamic therapy has been shown to induce strong immunity against tumor cells expressing exogenous tumor- associated antigens ( tA As), including P1A antigen.",OADS,/arxiv_data1/oa_pdf/7c/1b/onci-3-e28837.PMC4091536.pdf
CA Cancer J Clin 2011; 61:250-81; PMID :21617154 ; http://dx.doi.org/10.3322/ caac.20114 2.,Non-OADS,/arxiv_data1/oa_pdf/7c/1b/onci-3-e28837.PMC4091536.pdf
Photodiagn Photodyn  Ther  2005 ; 2:283-98; http://dx.doi.org/10.1016/ S1572-1000(05)00098-04.,OADS,/arxiv_data1/oa_pdf/7c/1b/onci-3-e28837.PMC4091536.pdf
Cancer Res 2013 ; 73:6462 -70;  PMID:24072749 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2572 7.,Non-OADS,/arxiv_data1/oa_pdf/7c/1b/onci-3-e28837.PMC4091536.pdf
Immunol Rev   2002 ; 188:22-32; PMID:12445278 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/1b/onci-3-e28837.PMC4091536.pdf
E ur J Cancer 2014 ; 50:1370 - 81; PMID:24559534 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/7c/1b/onci-3-e28837.PMC4091536.pdf
"OncoImmunology 2014; 3:e28963; http://dx.doi.org/10.4161/onci.28963Location, location, location The relationship of anatomic site, antigen expression,   and T-cell infiltration in human melanoma metastases edm und K Bartlett† and  uda i  s K ammula†,* Center for Cancer re search, surg ery Branch, National Cancer in stitute, National in stitutes of he alth, Bethesda, Maryland, usA †th ese authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/ed/e8/onci-3-e28963.PMC4091537.pdf
Hum Vaccin Immunother  2012; 8:1141-2;  PMID:22854675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/e8/onci-3-e28963.PMC4091537.pdf
N Engl J Med 2012 ; 366:883-92;  PMID:22397650 ; http://dx.doi.org/10.1056/ NEJMoa1113205 3.,OADS,/arxiv_data1/oa_pdf/ed/e8/onci-3-e28963.PMC4091537.pdf
Nat Genet 2011 ; 43:1119-26;  PMID:21946352 ; http://dx.doi.org/10.1038/ng.950 4.,OADS,/arxiv_data1/oa_pdf/ed/e8/onci-3-e28963.PMC4091537.pdf
J Exp Med  1996 ; 183:725-9; PMID:8642276 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/e8/onci-3-e28963.PMC4091537.pdf
Clin Cancer Res 2014 ;  20:2607 -16; PMID:24647571 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/e8/onci-3-e28963.PMC4091537.pdf
J Immunol 2008 ; 180:130- 7; PMID:18097012 ; http://dx.doi.org/10.4049/ jimmunol.180.1.130 10.,Non-OADS,/arxiv_data1/oa_pdf/ed/e8/onci-3-e28963.PMC4091537.pdf
2008. http://www.who.int/mediacentre/factsheets/fs310/en/ (accessed19 Jan 2010).,Non-OADS,/arxiv_data1/oa_pdf/1b/70/bmjopen-2014-004961.PMC4091538.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005381).,Non-OADS,/arxiv_data1/oa_pdf/51/22/bmjopen-2014-005381.PMC4091539.pdf
Revised 18 Feb 2013. http://www.who.int/healthinfo/survey/ageingdefnolder/en/ 15.,Non-OADS,/arxiv_data1/oa_pdf/51/22/bmjopen-2014-005381.PMC4091539.pdf
Revised 23 February 2013. http://www.pfizer.com/files/products/ uspi_viagra.pdf 50.,Non-OADS,/arxiv_data1/oa_pdf/51/22/bmjopen-2014-005381.PMC4091539.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005199).,Non-OADS,/arxiv_data1/oa_pdf/36/12/bmjopen-2014-005199.PMC4091540.pdf
June 2013. http://global.tobaccofreekids.org/files/pdfs/en/Global_Cigarette_Industry_pdf.pdf (accessed 1 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/36/12/bmjopen-2014-005199.PMC4091540.pdf
"Executive Yuan, Department of Statistics, 2013. http://sowf.moi.gov.tw/stat/year/list.htm (accessed 15 Aug 2013).",OADS,/arxiv_data1/oa_pdf/36/12/bmjopen-2014-005199.PMC4091540.pdf
http://www.mohw.gov.tw/EN/Ministry/ Statistic.aspx?f_list_no=474&fod_list_no=3480 (accessed 13 Jun2013).,Non-OADS,/arxiv_data1/oa_pdf/36/12/bmjopen-2014-005199.PMC4091540.pdf
http://sowf.moi.gov.tw/stat/english/elife/elist.htm(accessed 14 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/36/12/bmjopen-2014-005199.PMC4091540.pdf
http://www.dgbas.gov.tw/lp.asp?ctNode=4987&CtUnit=1183&BaseDSD=7 (accessed 15 May 2013).,OADS,/arxiv_data1/oa_pdf/36/12/bmjopen-2014-005199.PMC4091540.pdf
https://apps.nccd.cdc.gov/sammec/show_esaf_data.asp(accessed 8 May 2013).,OADS,/arxiv_data1/oa_pdf/36/12/bmjopen-2014-005199.PMC4091540.pdf
"(Taiwan), 2012. http://www.tma.tw/se_dis/42.asp (accessed 21 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/36/12/bmjopen-2014-005199.PMC4091540.pdf
"Plant Signaling & Behavior 2014; 9:e28169; PMID: 24603547; http://dx.doi.org/10.4161/psb.28169 Addendum to: Chormova D, Messenger  DJ, Fry  SC.",OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
Plant J  2014 ;  77:534-46; http://dx.doi.org/10.1111/tpj.12403 ;  PMID:24320597,OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
J Plant Nutr Soil Sci 2007; 170:39-48; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
For Ecol Manage 2010; 260:2053- 69; http://dx.doi.org/10.1016/j.foreco.2010.09.0285.,OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
Plant Cell Environ 2012; 35:719-34;  PMID:21988710 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
Plant Sci 2013; 203-204:25-32;   PMID :23415325 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
J Exp Bot 1996; 47:227-32; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
Plant Cell Physiol 1996;  37:636-40; http://dx.doi.org/10.1093/oxfordjourn - als.pcp.a02899212.,Non-OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
Plant Physiol 2001; 126:1698-705; PMID :11500567 ;  http://dx.doi.org/10.1104/pp.126.4.1698 13.,Non-OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
Identification of the connecting  linkage between homo- or xylogalacturonan and rhamnogalacturonan type I. Carbohydr Polym  2007; 70:224-35; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
Plant  J 2014; 77:534-46; http://dx.doi.org/10.1111/ tpj.12403 ; PMID:24320597 15.,OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
Glycobiology  2006; 16:29-35;  PMID:16049187 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
J Biol Chem 1996; 271:22923-30; PMID:8798473 ; http://dx.doi.org/10.1074/ jbc.271.37.22923 17.,OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
Ann Bot 2005; 96:91-9; PMID:15837720 ;  http://dx.doi.org/10.1093/aob/mci153 18.,Non-OADS,/arxiv_data1/oa_pdf/33/c0/psb-9-e28169.PMC4091542.pdf
"Current  studies in many laboratories examine  these issues, but a consensus has not yet  been formed; even the role of wild type The challenge in translating basic research discoveries to treatment of  Huntington disease Daria Mochly-Rosen1,*, Marie-Helene Disatnik1, and Xin Qi2 1Department of Chemical and Systems Biology; Stanford University School of Medicine; Stanford, CA USA; 2Department of Physiology & Biophysics;   Center of Mitochondrial Disease; Case Western Reserve University School of Medicine; Cleveland, OH USA Keywords:  Huntington disease,  neurodegeneration, mitochondria,  polyglutamine, animal model, protein- protein interactions, P110 peptide  inhibitor, Drp1 *Correspondence to: Daria Mochly-Rosen;   Email: mochly@stanford.edu Submitted: 12/16/2013; Revised:  03/03/2014; Accepted: 03/24/2014;  Published Online: 03/31/2014 http://dx.doi.org/10.4161/rdis.28637 Addendum to: Guo X, Disatnik MH, Monbureau  M, Shamloo M, Mochly-Rosen D, Qi X.  Inhibition of mitochondrial fragmentation  diminishes Huntington’s disease-associated  neurodegeneration.",Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
J Clin Invest 2013; 123:5371- 88; PMID:24231356; http://dx.doi.org/10.1172/ JCI70911,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
J Clin Invest 2013;  123:5371-88;  PMID:24231356 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Cell 1993;  72:971-83;  PMID:8458085 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Biochem J 2008; 412:191-209;  PMID:18466116 ;  http://dx.doi.org/10.1042/BJ20071619 4.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Hum Mol Genet 2005; 14:765-74;   PMID :15689354 ; http://dx.doi.org/10.1093/hmg/ ddi071 5.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Nat Rev Neurosci 2008; 9:505- 18; PMID:18568013 ; http://dx.doi.org/10.1038/ nrn2417 6.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Trends Genet  2003; 19:233-8;  PMID:12711212 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Trends Genet  2004; 20:146-54;  PMID :15036808 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Neuron 2012; 75:41-57;  PMID:22794259 ;  http://dx.doi.org/10.1016/j.neuron.2012.05.024 9.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
FEBS J  2008; 275:4271-9;  PMID:18637945 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Proc Natl Acad Sci U S A 2000; 97:6809- 14; PMID:10829080 ; http://dx.doi.org/10.1073/ pnas.120166397 12.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Prog Mol Biol Transl Sci 2011; 100:419-82;   PMID:21377633 ; http://dx.doi.org/10.1016/ B978-0-12-384878-9.00012-1 13.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Mol Neurobiol 2012; 46:430- 66; PMID:22944909 ; http://dx.doi.org/10.1007/ s12035-012-8316-315.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
J Clin Invest 2011; 121:476-83;  PMID:21285520 ;  http://dx.doi.org/10.1172/JCI45364 16.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Hum Mol Genet 2012;  21:406-20;  PMID:21997870 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Nat Med 2011;  17:377-82;  PMID:21336284 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
J Cell Sci 2013; 126:789- 802; PMID:23239023 ; http://dx.doi.org/10.1242/ jcs.114439 20.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Hum  Mol Genet 2013; 22:4545-61;  PMID:23813973 ;  http://dx.doi.org/10.1093/hmg/ddt301 21.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Nature  2012; 481:295-305;  PMID:22258608 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
J Neurosci 2011; 31:17649- 58; PMID:22131425 ; http://dx.doi.org/10.1523/ JNEUROSCI.4871-11.2011 25.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Cell 2006;  127:59-69;  PMID:17018277 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Lancet Neurol  2011; 10:573-90;  PMID:21601164 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Neurology 2006; 66:250-2;   PMID:16434666 ; http://dx.doi.org/10.1212/01.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Dis Markers  2006; 22:39-64;  PMID:16410651 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Proc Natl Acad Sci U S A  2011; 108:17141-6;  PMID:21969577 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Cell 1996; 87:493-506;  PMID:8898202 ;  http://dx.doi.org/10.1016/S0092-8674(00)81369-0 35.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
J Comp Neurol 2003; 465:11-26;  PMID:12926013 ;  http://dx.doi.org/10.1002/cne.10776 37.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Hum Mol Genet 2000; 9:503- 13; PMID:10699173 ; http://dx.doi.org/10.1093/ hmg/9.4.503 38.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
J Neurosci 2008; 28:6182-95;   PMID:18550760 ; http://dx.doi.org/10.1523/ JNEUROSCI.0857-08.2008 41.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Hum  Mol Genet 2003; 12:1555-67;  PMID:12812983 ;  http://dx.doi.org/10.1093/hmg/ddg169 42.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Neuron 1999; 23:181- 92; PMID:10402204 ; http://dx.doi.org/10.1016/ S0896-6273(00)80764-3 43.,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
"J Neurosci 2012; 32:15426-38;   PMID :23115180 ; http://dx.doi.org/10.1523/ JNEUROSCI.1148-12.2012 44. von Hörsten S, Schmitt I, Nguyen HP, Holzmann C,  Schmidt T, Walther T, Bader M, Pabst R, Kobbe P,  Krotova J, et al.",OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
Hum Mol Genet 2003; 12:617-24;   PMID:12620967 ; http://dx.doi.org/10.1093/hmg/ ddg075,OADS,/arxiv_data1/oa_pdf/20/c6/rdis-2-e28637.PMC4091548.pdf
"Plant Signaling & Behavior 2014; 9:e28891; PMID: 24739253; http://dx.doi.org/10.4161/psb.28891Arabidopsis thaliana  glucuronosyltransferase   in family GT14 adiphol Dilokpimol†and n aomi Geshi* Department of Plant and Environmental Sciences; u niversity of Copenhagen; Frederiksberg C, Denmark †Current address: Fungal Physiology; CBS-K naW Fungal Biodiversity Center; u trecht, t he n etherlands Keywords:  CAZy GT14, Arabidopsis thaliana , glucuronosyltransferase, glucuronic acid,   glycosyltransferase, arabinogalactan, proteoglycan, plant cell walls arabinogalactan proteins are abundant cell-surface proteoglycans in plants and are involved in many cellular  processes including somatic embryogenesis, cell-cell interactions, and cell elongation.",OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
"The  transcript-levels for AtGlcAT14A , B, and C  are low to medium  throughout development of Arabidopsis and they have rather  similar expression profiles (Genevestigator: http://www.gene - vestigator.com/gv/).",Non-OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
Supplemental Material Supplemental material may be found here:   https://www.landesbioscience.com/journals/psb/article/2889 1  References 1.,Non-OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
Annu Rev Plant Biol 2007; 58:137- 61; PMID:17201686 ; http://dx.doi.org/10.1146/ annurev.arplant.58.032806.103801 2.,OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
Plant J 2013; 76:1016-29; PMID:24128328 ; http://dx.doi.org/10.1111/ tpj.12353 3.,OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
New Phytol 2013; 197:58-64;  PMID:23106282 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
Biotechnol Bioeng 2005; 90:578-88; PMID :15818563 ; http://dx.doi.org/10.1002/ bit.20441 6.,Non-OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
Plant Physiol 1989;  90:567-74;  PMID:16666809 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
Appl Environ Microbiol 2008; 74:2379-83;   PMID:18310439 ; http://dx.doi.org/10.1128/ AEM.01733-078.,OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
J  Biol Chem 2005; 280:25820-9; PMID :15866877 ;  http://dx.doi.org/10.1074/jbc.M501024200 9.,OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
PLoS One 2007; 2:e718;  PMID:17684564 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/a1/psb-9-e28891.PMC4091549.pdf
"OncoImmunology 2014; 3:e28977;http://dx.doi.org/10.4161/onci.28977Type II natural killer T cells foster the antitumor  activity of CpG-oligodeoxynucleotides Jie Zhao, sr eya Bagchi, and Chyung- ru  wa ng* Department of Microbiology and im munology; Feinberg sc hool of Medicine; Northwestern un iversity; Chicago, iL usA Keywords:  CD1, NKT cells, tumor immunity, immunotherapy ty pe ii  natural killer t  (NK t) c ells in cancer immunity are typically associated with suppression of tumor  immunosurveillance through secretion of  iL -13.  we p reviously demonstrated that CpG oligonucleotide therapy activated  ty pe  ii  NKt  cells to produce  t  helper type 1 ( th 1) rather than  t  helper type 2 ( th 2) cytokines.",Non-OADS,/arxiv_data1/oa_pdf/2d/e3/onci-3-e28977.PMC4091550.pdf
J Immunol 2001; 167:5531-4; PMID:11698421 ; http://dx.doi.org/10.4049/ jimmunol.167.10.5531 2.,Non-OADS,/arxiv_data1/oa_pdf/2d/e3/onci-3-e28977.PMC4091550.pdf
Proc Natl Acad Sci U S  A 2014 ; 111:2674 -9; PMID:24550295 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/e3/onci-3-e28977.PMC4091550.pdf
J Immunol 2008 ; 180:3627 - 35; PMID:18322166 ; http://dx.doi.org/10.4049/ jimmunol.180.6.36274.,Non-OADS,/arxiv_data1/oa_pdf/2d/e3/onci-3-e28977.PMC4091550.pdf
Immunity 2007 ; 27:597-609;  PMID:17950005 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2d/e3/onci-3-e28977.PMC4091550.pdf
J Immunol 2008 ; 181:4452 -6; PMID:18802047 ;  http://dx.doi.org/10.4049/jimmunol.181.7.4452 6.,Non-OADS,/arxiv_data1/oa_pdf/2d/e3/onci-3-e28977.PMC4091550.pdf
Proc Natl Acad Sci U S A 2009 ; 106:1909 - 14; PMID:19179286 ; http://dx.doi.org/10.1073/ pnas.0808476106 7.,Non-OADS,/arxiv_data1/oa_pdf/2d/e3/onci-3-e28977.PMC4091550.pdf
Blood   2011 ; 118:3870 -8; PMID:21860021 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/e3/onci-3-e28977.PMC4091550.pdf
"Nat Immunol  2010 ; 11:1102 -9; PMID:21037579 ;  http://dx.doi.org/10.1038/ni.1956 9.  d e Lalla C, Lepore  M, Piccolo  FM, Rinaldi  A, Scelfo   A, Garavaglia  C, M ori  L, De Libero G, Dellabona   P, Casorati  G. High-frequency and adaptive-like  dynamics of human CD1 self-reactive T cells.",OADS,/arxiv_data1/oa_pdf/2d/e3/onci-3-e28977.PMC4091550.pdf
"OncoImmunology 2014; 3:e29030; http://dx.doi.org/10.4161/onci.29030Trial watch Immunostimulatory cytokines in cancer therapy er ika Vacchelli1,2,3,4,†, Fernando Aranda1,2,3,4,†, Florine  ob rist1,2,3,4, Alexander  eg germont1, Jérôme Galon2,5,6,7, is abelle Cremer2,6,8,  Laurence Zitvogel1,9, Guido Kroemer2,3,5,10,11,‡, and Lorenzo Galluzzi1,3,5,‡ 1Gustave ro ussy; Villejuif, France; 2iNs er M , uMr s1 138; Paris, France; 3eq uipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de re cherche des Cordeliers; Paris,  France; 4un iversité Paris- su d/Paris X i;  Le Kremlin-Bicêtre, France; 5un iversité Paris Descartes/Paris V, so rbonne Paris Cité; Paris, France; 6un iversité Pierre et Marie Curie/Paris V i;   Paris, France; 7Laboratory of in tegrative Cancer im munology, Centre de re cherche des Cordeliers; Paris, France; 8eq uipe 13, Centre de re cherche des Cordeliers; Paris, France;  9iNs er M , u1 015, C iC Bt5 07; Villejuif, France; 10Pôle de Biologie, hôpi tal eu ropéen Georges Pompidou, AP- h P , Paris, France;   11Metabolomics and Cell Biology Platforms, Gustave ro ussy; Villejuif, France;  †th ese authors contributed equally contributed to this work.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
"Third, interleukin (IL)-2 (aldesleukin, Proleukin ®) is approved  for the treatment of metastatic forms of melanoma and renal cell carcinoma (RCC) (source http://www.fda.gov).",Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
"www.landesbioscience.com  o ncoimmunology  e29030-3Literature Update Since the submission of our latest Trial  Watch dealing with topic (April 2013),5  the results of at least 10 clinical studies  evaluating the therapeutic profile of cytokines as off-label immunostimulatory interventions in cancer patients have been published in peer-reviewed scientific journals (source http://www.ncbi.nlm.nih.gov/pubmed).",Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
"96,97Update on Ongoing Clinical Trials When this Trial Watch was being  redacted (April 2014), official sources listed no less than 88 clinical trials launched after May 1st, 2013 that would evaluate the efficacy and safety of immunostimulatory cytokines in cancer patients (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
"This is a novel application for recombinant human FLT3L (also known as CDX-301), which is being developed as an alternative or a support to G-CSF for the mobilization of hematopoietic cell precursors in bone marrow donors, with promising results (source http://www.celldex.com/).",Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
"www.landesbioscience.com  o ncoimmunology  e29030-7with results; as well as NCT00601796,  NCT00660270, NCT00719264 NCT00891475, NCT01021059, NCT01220648, NCT01404936, NCT01592045, NCT01637532, NCT01639885 and NCT01673217, which have been completed (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology   2013 ; 2:e24850 ; PMID:24073369 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology   2012 ; 1:493-506; PMID:22754768 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nat Rev Immunol 2013 ; 13:544- 5; PMID:23827957 ; http://dx.doi.org/10.1038/ nri3496 8.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Allergy Clin Immunol 2003 ; 111(Suppl ):S460 -75;  PMID:12592293 ; http://dx.doi.org/10.1067/ mai.2003.108 9.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Allergy Clin Immunol 2006 ; 117(Suppl Mini- Primer ):S441 -5; PMID:16455343 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nat Rev Cancer 2010 ; 10:425-34; PMID:20495576 ;  http://dx.doi.org/10.1038/nrc2843 11.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Curr Pharm Des  2006 ; 12:3101 -15; PMID:16918437 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nature   1990 ; 348:550-2; PMID:2147233 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nature   1987 ; 330:662-4; PMID:3317066 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Immunol Cell Biol   2011 ; 89:739-46; PMID:21263463 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nat Immunol   2005 ; 6: 1191-7; PMID:16369558 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Trends Immunol  2013 ; 34:471-81;  PMID:23891238 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nat Rev Cancer 2004 ; 4:11-22;  PMID:14708024 ; http://dx.doi.org/10.1038/ nrc1252 20.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Science  2013 ; 339:286-91; PMID:23329041 ;  http://dx.doi.org/10.1126/science.123222722.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology   2013 ; 2:e25771 ; PMID:24286020 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2014 ; 3:e28185 ;  PMID:24800178 ; http://dx.doi.org/10.4161/ onci.28185 24.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2013 ; 2:e26621 ;  PMID:24498550 ; http://dx.doi.org/10.4161/ onci.26621 25.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2013 ; 2: e25238 ;  PMID:24083080 ; http://dx.doi.org/10.4161/ onci.25238 26.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cell Death Differ  2014 ; 21:69-78; PMID:23811849 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology   2014 ; 3:e27297 ; PMID:24701370 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Biologics  2008 ; 2:13- 27; PMID:19707424 ; http://dx.doi.org/10.2147/ BTT.S1355 29.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Br J  Haematol  2002 ; 116:468-74; PMID:11841454 ;  http://dx.doi.org/10.1046/j.1365-2141.2002.03264.x 33.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
BMC Cancer  2013 ; 13:11; PMID:23298389 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Clin Oncol 2012 ; 30:1064 - 71; PMID:22393098 ; http://dx.doi.org/10.1200/ JCO.2011.36.8647 35.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Blood  2012 ; 119:5367 - 73; PMID:22422824 ; http://dx.doi.org/10.1182/ blood-2011-11-389841 36.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Clin Oncol  2011 ; 29:4036 -44; PMID:21931039 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
"Ann Surg 1996 ; 224:756-64,  discussion 764-5 ; PMID:8968230 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cancer Treat Res  1997 ; 91:189-203; PMID:9286497 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Clin Oncol 2012 ;  30:3810 -8; PMID:23008300 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Surg Oncol  2012 ; 106:921-8; PMID:22806575 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Blut 1989 ; 58:275-8;  PMID:2736308 ; http://dx.doi.org/10.1007/ BF00320165 52.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Natl Cancer Inst 2007 ; 99:196-205;  PMID:17284714 ; http://dx.doi.org/10.1093/jnci/ djk028 53.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Ann Oncol  2005 ; 16:1209 -10; PMID :15857847 ;  http://dx.doi.org/10.1093/annonc/mdi201 54.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Blood  2003 ; 101:3862 - 7; PMID:12531808 ; http://dx.doi.org/10.1182/ blood-2002-08-2405 55.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
OncoImmunology  2013 ; 2:e24238 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nat Rev Drug Discov 2012 ; 11:215-33;  PMID:22301798 ; http://dx.doi.org/10.1038/ nrd3626 57.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Invest Dermatol   2013 ; 133:1462 -5; PMID:23673502 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Interferon Cytokine Res 2014 ;  34:376-84; PMID:24433038 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Ann Oncol   2006 ; 17:1733 -42; PMID:16801334 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Trends Pharmacol Sci  2013 ; 34:676-88;  PMID:24183675 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Clin Endocrinol Metab 2013 ;  98:E1567 -74; PMID:23884781 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2012 ; 1: 894-907;  PMID:23162757 ; http://dx.doi.org/10.4161/ onci.20931 66.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Neuroimmunol   2013 ; 259:17-25; PMID:23582490 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Recent Pat  Endocr Metab Immune Drug Discov 2011 ;  5:109-23; PMID:22074586 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2014 ; 3:e27048 ;  PMID:24605265 ; http://dx.doi.org/10.4161/ onci.27048 72.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
"N Engl J Med 2002 ;  346:1830 -1, author reply 1830-1 ; PMID:12050349 ;  http://dx.doi.org/10.1056/NEJM200206063462317 73.",OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
N Engl J Med  2002 ; 346:235-42; PMID:11807147 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Immunother  2013 ; 36:331-41; PMID:23799412 ;  http://dx.doi.org/10.1097/CJI.0b013e31829d7e2e 75.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology   2012 ; 1: 28-37; PMID:22720209 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Clin Oncol  2012 ; 30:426-32; PMID:22203761 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Int  J Cancer 2014 ; (Forthcoming ); PMID:24644014 ;  http://dx.doi.org/10.1002/ijc.28851 83.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2012 ; 1: 477-86;  PMID:22754766 ; http://dx.doi.org/10.4161/ onci.19864 84.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Drug Des Devel Ther 2013 ; 7: 611-7;  PMID:23901264 ; http://dx.doi.org/10.2147/ DDDT.S43184 85.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Chemother  2013 ; 25:362-8;  PMID:24093213 ; http://dx.doi.org/10.1179/197394 7813Y.0000000102 86.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Eur Urol  2013 ; 63:745-52;  PMID:23063454 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Clin Oncol 2007 ; 25:2785 - 91; PMID:17602083 ; http://dx.doi.org/10.1200/ JCO.2006.09.8897 88.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nat Rev Drug Discov  2007 ; 6:734-45; PMID:17690708 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
N Engl J Med  2007 ; 356:115-24; PMID:17215529 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Lancet  2007 ;  369:1923 -4; PMID:17560435 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cancer Chemother Pharmacol   2014 ; 73:151-61; PMID:24220935 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nat Med   2013 ; 19:730-8; PMID:23685841 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Clin Invest  2014 ; 124:99-110; PMID:24292706 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Science  2014 ;  343:1249288 ; PMID:24625929 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Clin Invest 2013 ; 123:2604 -15; PMID:23676462 ;  http://dx.doi.org/10.1172/JCI67008 96.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cancer Gene Ther   2012 ; 19:637-43; PMID:22790963 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Clin Cancer Res 2012 ; 18:2039 -47;  PMID:22271879 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-1823 98.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2013 ; 2:e24238 ;  PMID:23762803 ; http://dx.doi.org/10.4161/ onci.24238 99.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
N Engl J Med 2005 ; 353:1673 -84;  PMID:16236738 ; http://dx.doi.org/10.1056/ NEJMoa052122 100.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
N Engl J Med 2005 ; 353:1659 -72; PMID:16236737 ;  http://dx.doi.org/10.1056/NEJMoa052306 101.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2013 ; 2:e24567 ;  PMID:23802090 ; http://dx.doi.org/10.4161/ onci.24567 102.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Lancet  2010 ; 376:687- 97; PMID:20728210 ; http://dx.doi.org/10.1016/ S0140-6736(10)61121-X 103.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Lancet  2010 ; 375:377- 84; PMID:20113825 ; http://dx.doi.org/10.1016/ S0140-6736(09)61964-4104.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Lancet  2007 ; 369:29- 36; PMID:17208639 ; http://dx.doi.org/10.1016/ S0140-6736(07)60028-2 105.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
N Engl J Med 2010 ; 363:711-23;  PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa1003466 106.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2013 ; 2: e26535 ;  PMID:24244910 ; http://dx.doi.org/10.4161/ onci.26535 107.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
N Engl J Med  2011 ; 364:2517-26; PMID:21639810 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nat Biotechnol   2013 ; 31:71-5; PMID:23242161 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Immunol Methods 2010 ; 359:11- 20; PMID:20460126 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2013 ; 2:e23402 ;  PMID:23802080 ; http://dx.doi.org/10.4161/ onci.23402 111.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Expert Opin  Biol Ther  2012 ; 12:873-90; PMID:22679911 ;  http://dx.doi.org/10.1517/14712598.2012.685153 112.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cancer Immunol  Immunother  2012 ; 61:2261 -71; PMID:22678096 ;  http://dx.doi.org/10.1007/s00262-012-1286-5 113.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Drug Discov Today  2012 ; 17:583-90; PMID:22289353 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
"B rack SS, Silacci  M, Birchler  M, Neri D. Tumor- targeting properties of novel antibodies specific to the large isoform of tenascin-C. Clin Cancer Res  2006 ; 12:3200 -8; PMID:16707621 ; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Cancer Res  Clin Oncol  2013 ; 139:447-55; PMID:23160853 ;  http://dx.doi.org/10.1007/s00432-012-1327-7 117.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Eur J Cancer 2010 ; 46:2926 - 35; PMID:20797845 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2013 ;  2:e25595 ; PMID:24319634 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
N Engl J Med 2010 ; 363:411- 22; PMID:20818862 ; http://dx.doi.org/10.1056/ NEJMoa1001294 120.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nature  2013 ; 504:S6-8; PMID:24352363 ;  http://dx.doi.org/10.1038/504S6a 122.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2012 ; 1: 773- 6; PMID:22934279 ; http://dx.doi.org/10.4161/ onci.19729 1 25.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2013 ; 2:e22730 ;  PMID:23524978 ; http://dx.doi.org/10.4161/ onci.22730 126.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2012 ; 1: 618-29;  PMID:22934254 ; http://dx.doi.org/10.4161/ onci.20249 127.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Clin Oncol 2011 ; 29:330- 6; PMID:21149657 ; http://dx.doi.org/10.1200/ JCO.2010.30.7744 130.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Transl Med  2007 ; 5: 67; PMID:18093335 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2012 ; 1:1661 -3; PMID:23264929 ;  http://dx.doi.org/10.4161/onci.22033 132.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology   2012 ; 1:69 9 -716; PMID:22934262 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cancer Immunol Immunother  2010 ; 59:1467- 79; PMID:20532500 ; http://dx.doi.org/10.1007/ s00262-010-0871-8 135.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Immunother   2012 ; 35:359-66; PMID:22495394 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cancer Res  2013 ; 73:19-29; PMID:23087058 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cancer Res 2012 ; 72:6102 -10;  PMID:23010076 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-2479 138.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Asian Pac J Cancer Prev 2013 ;  14:3109 -16; PMID:23803088 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Clin  Cancer Res 2011 ; 17:6467 -81; PMID:21810919 ;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0812 141.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Nat Rev Drug Discov 2004 ; 3: 995-6;  PMID:15645606 ; http://dx.doi.org/10.1038/ nrd1601 142.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Immunother  2012 ; 35:670- 9; PMID:23090076 ; http://dx.doi.org/10.1097/ CJI.0b013e318270e135 144.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Clin Exp Immunol  2011 ; 163:381-91; PMID:21235535 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cancer Res 2009 ; 69:7747 -55;  PMID:19738077 ; http://dx.doi.org/10.1158/0008- 5472.CAN-08-3289 146.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2012 ; 1:306- 15; PMID:22737606 ; http://dx.doi.org/10.4161/ onci.19549 147.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Ann Surg 2008 ; 248:145- 51; PMID:18650621 ; http://dx.doi.org/10.1097/ SLA.0b013e318181e4e9 148.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Science  2013 ; 342:1432 - 3; PMID:24357284 ; http://dx.doi.org/10.1126/ science.342.6165.1432 149.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2012 ; 1:407- 8; PMID:22754758 ; http://dx.doi.org/10.4161/ onci.20074 150.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Blood  2006 ; 107:2409 - 14; PMID:16304057 ; http://dx.doi.org/10.1182/ blood-2005-06-2399 152.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
J Clin Oncol 2006 ; 24:1169 - 77; PMID:16505437 ; http://dx.doi.org/10.1200/ JCO.2005.03.6830 ©2014 Landes Bioscience.,OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cancer Res  2007 ; 67:7487 -94; PMID:17671219 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Eur J Immunol 2008 ; 38:1643 -53; PMID:18493984 ;  http://dx.doi.org/10.1002/eji.200737791 155.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Cancer Immunol Immunother  2013 ;  62:897-908; PMID:23589107 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
Oncoimmunology  2012 ; 1:1323 - 43; PMID:23243596 ; http://dx.doi.org/10.4161/ onci.22009 ©2014 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/onci-3-e29030.PMC4091551.pdf
"OncoImmunology 2014; 3:e28610; http://dx.doi.org/10.4161/onci.28610Anti-human CD40 monoclonal antibody therapy is  potent without FcR crosslinking Lee P ri chman and  ro bert  h  Vonderheide* Abramson Family Cancer re search in stitute; Perelman sc hool of Medicine; un iversity of Pennsylvania; Philadelphia, PA usA Keywords:  CD40, Fc receptor, tumor immunity, immunotherapy Antibody agonists targeting tumor necrosis factor ( tN F) superfamily receptors, including CD40, are being tested  therapeutically as anticancer agents.",Non-OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
Clin Cancer Res  2013; 19:1035-43;  PMID:23460534 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
Cancer Immunol Immunother 2013; 62:941-8; PMID :23543215 ; http://dx.doi.org/10.1007/ s00262-013-1398-6 3.,Non-OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
Science 2011; 331:1612-6; PMID:21436454 ; http://dx.doi.org/10.1126/ science.1198443 4.,Non-OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
J Clin Oncol 2007; 25:876-83; PMID:17327609 ; http://dx.doi.org/10.1200/ JCO.2006.08.33115.,Non-OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
Int Immunol 1999; 11:11-20;  PMID:10050669 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
Immunology 2001; 102:39-43;  PMID:11168635 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
Cancer Immunol Res 2014; 2:19-26;  PMID:24416732 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
J Immunol 2011; 187:1754-63; PMID:21742972 ; http://dx.doi.org/10.4049/ jimmunol.1101135 9.,Non-OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
Science 2011; 333:1030-4; PMID:21852502 ; http://dx.doi.org/10.1126/ science.1206954 10.,Non-OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
Cancer Cell 2011; 19:101-13; PMID :21251615 ;  http://dx.doi.org/10.1016/j.ccr.2010.11.012Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/24/58/onci-3-e28610.PMC4091558.pdf
"Mobile Genetic Elements 2014; 4:e29782; http://dx.doi.org/10.4161/mge.29782 *Correspondence: Tiziana Mascia;   Email: tiziana.mascia@uniba.it; Peter Palukaitis; Email: scripath1@yahoo.co.uk Commentary to: Mascia T, Nigro F, Abdallah A, Ferrara M, De Stradis A, Faedda R, Palukaitis P , Gallitelli D. Gene silencing and gene expression in phytopathogenic fungi using a plant virus vector.",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Proc Natl Acad Sci U S A 2014; 111:4291–6; PMID:24594602 ; http://dx.doi.org/10.1073/ pnas .13156 6 8111,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Virology 2012; 433:1-6; PMID:22979981 ;  http://dx.doi.org/10.1016/j.virol.2012.06.012 2.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Trends Plant Sci  2011 ; 16:656-65; PMID:21937256 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Nat  Rev Immunol  2010 ; 10:632-44; PMID:20706278 ;  http://dx.doi.org/10.1038/nri2824 4.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
EMBO J 2011 ; 30:3553 -63; PMID:21878996 ;  http://dx.doi.org/10.1038/emboj.2011.274 5.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Adv Virus Res 2011 ; 80:25- 48; PMID:21762820 ; http://dx.doi.org/10.1016/ B978-0-12-385987-7.00002-6 7.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Mol Plant  Microbe Interact  2011 ; 24:554-61; PMID:21190437 ;  http://dx.doi.org/10.1094/MPMI-10-10-0229 8.,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Plant Physiol  2012 ; 160:582- 90; PMID:22885938 ; http://dx.doi.org/10.1104/ pp.112.203489 9.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Biotechnol Adv   2008 ; 26:177-85; PMID:18201856 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
BMC Biol  2010 ; 8:27; PMID:20356372 ;  http://dx.doi.org/10.1186/1741-7007-8-27 12.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Plant J   2013a ; 73:521-32; PMID:23110316 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Plant Mol Biol  2013b ; 81:595- 608; PMID:23417582 ; http://dx.doi.org/10.1007/ s11103-013-0022-7 14.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Plant  Biotechnol J  2014 ; 12:541-53; PMID :24476152 ;  http://dx.doi.org/10.1111/pbi.12158 16.,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
J Virol 2000 ; 74:7568 - 77; PMID:10906211 ; http://dx.doi.org/10.1128/ JVI.74.16.7568-7577.2000 17.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Annu Rev Phytopathol  1966 ; 4:29-52; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Neth J Plant Pathol 1969 ; 75:296-9; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Phytopathol Z  1977 ; 90:184-8; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Proc Natl Acad Sci U S A  2014 ; 111:4291 -6; PMID:24594602 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Front Plant Sci  2013 ;  4:12; PMID:23403525 ; http://dx.doi.org/10.3389/ fpls.2013.00012 23.,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Appl Microbiol Biotechnol  2013 ; 97:9277 -90;  PMID:24077722 ; http://dx.doi.org/10.1007/ s00253-013-5221-2 25.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Neth J Plant Pathol 1970 ; 76:229-33; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Plant J  2002 ;  31:777-86; PMID:12220268 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
Transgenic Res  2007 ; 16:587- 97; PMID:17216546 ; http://dx.doi.org/10.1007/ s11248-006-9051-1 29.,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
J Virol Methods 2010 ; 164:7-13; PMID:19903495 ;  http://dx.doi.org/10.1016/j.jviromet.2009.11.005,OADS,/arxiv_data1/oa_pdf/6e/0f/mge-4-e29782.PMC4091559.pdf
"Plant Signaling & Behavior 2014; 9:e28724; PMID: 24731991; http://dx.doi.org/10.4161/psb.28724Emerging role of SGT1 as a regulator of NB-LRR- receptor nucleocytoplasmic partitioning rafał h oser, m ałgorzata Lichocka, m arek Żurczak, Jacek h ennig, and m agdalena Krzymowska* institute of Biochemistry and Biophysics P aS; Warsaw, Poland Keywords:  plant disease resistance, nucleocytoplasmic shuttling, NB-LRR, N, Rx, SGT1 Plant nucleotide-binding ( nB) and leucine-rich repeat (Lrr ) receptors mediate effector-triggered immunity.",OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Methods Mol Biol 2008;  451:3-19;  PMID:18370244 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
EMBO J 2006 ; 25:2007 -16;  PMID:16619029 ; http://dx.doi.org/10.1038/ sj.emboj.76010843.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Plant Cell  2007 ;  19:3791 -804; PMID:18032631 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
J Biol Chem 2004 ; 279:2101 - 8; PMID:14583611 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Plant Cell  2010 ; 22:4195 - 215; PMID:21177483 ; http://dx.doi.org/10.1105/ tpc.110.077537 7.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Plant Physiol  2013 ; 161:2049 - 61; PMID:23396834 ; http://dx.doi.org/10.1104/ pp.112.209023 8.,Non-OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Plant Cell  2006 ; 18:491-501;  PMID:16387833 ; http://dx.doi.org/10.1105/ tpc.105.037234 9.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Biochim Biophys Acta  2012 ; 1823 :689- 97; PMID:22001401 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Plant Cell  2007 ;  19:1682 -94; PMID:17526750 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Curr  Opin Plant Biol 2012 ; 15:375-84; PMID:22658703 ;  http://dx.doi.org/10.1016/j.pbi.2012.05.001 15.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Cell 1994 ;  78:1101 -15; PMID:7923359 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
PLoS Biol  2007 ; 5:e68; PMID:17298188 ;  http://dx.doi.org/10.1371/journal.pbio.0050068 19.,Non-OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Plant Mol Biol  2006 ; 61:31-45; PMID:16786290 ;  http://dx.doi.org/10.1007/s11103-005-5817-8 20.,Non-OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
PLoS Pathog  2013 ;  9:e1003235 ; PMID:23516366 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
J Gen Plant Pathol   2004 ; 70:221-31; http://dx.doi.org/10.1007/ s10327-003-0113-4 23.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
Cell 2008 ; 132:449- 62; PMID:18267075 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/e7/psb-9-e28724.PMC4091561.pdf
"To  date, many mutations including missense,  nonsense, and deletion mutations  scattered throughout the ORF, are linked  to AOA2,14 and eight mutations associated  with ALS4 have been described.13,15-17 It is  important to note that a growing number  of SETX  mutations have been found  in patients that display atypical and/or SETX sumoylation A link between DNA damage and RNA surveillance disrupted in AOA2 Patricia Richard and James L Manley * Department of Biological Sciences; Columbia University; New York, NY USA Keywords:  senataxin, Rrp45, exosome,  sumoylation, R loops, AOA2, ALS4 *Correspondence to: James L Manley; Email: jlm2@ columbia.edu Submitted: 11/20/2013; Revised:  12/18/2013; Accepted: 01/06/2014;  Published Online: 01/21/2014 http://dx.doi.org/10.4161/rdis.27743 Addendum to: Richard  P, Feng S, Manley  JL.",Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Genes Dev  2013; 27:2227- 32; PMID:24105744 ; http://dx.doi.org/10.1101/ gad.224923.113,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Biochemistry 1999; 38:14697-710;  PMID:10545196 ;  http://dx.doi.org/10.1021/bi991470c 2.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Mol Cell  2006 ; 24:735-46;  PMID:17157256 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Mol Cell  2011 ; 42:794-805;  PMID:21700224 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Mol Cell   2012 ; 46:115-24; PMID:22541554 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Mol  Cell 2011 ; 41:21-32; PMID:21211720 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Cell 2012 ; 151:835- 46; PMID:23141540 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Mol Cell Biol  2013 ; 33:406- 17; PMID:23149945 ; http://dx.doi.org/10.1128/ MCB.01195-12 10.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
PLoS Genet   2013 ; 9:e1003435 ; PMID:23593030 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Am  J Hum Genet  2004 ; 74:1128 -35; PMID:15106121 ;  http://dx.doi.org/10.1086/421054 14.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Amyotroph Lateral Scler  2011 ; 12:223-7;  PMID:21190393 ; http://dx.doi.org/10.3109/174829 68.2010.545952 16.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Amyotroph  Lateral Scler  2009 ; 10:118-22; PMID:19058054 ;  http://dx.doi.org/10.1080/17482960802572673 17.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
J  Neurol Neurosurg Psychiatry  2012 ; 83:763-4;  PMID:22577233 ; http://dx.doi.org/10.1136/ jnnp-2012-302281 18.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
J Neurol  2008 ;  255:495-501; PMID:18350359 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Neuromuscul Disord  2012 ; 22:258-62;  PMID:22088787 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Neurogenetics  2007 ; 8:45- 9; PMID:17096168 ; http://dx.doi.org/10.1007/ s10048-006-0067-8 21.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Brain Dev  2013 ;  PMID:24183476 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Ann Neurol  2005 ; 57:408-14;  PMID:15732101 ; http://dx.doi.org/10.1002/ ana.20408 23.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nucleic Acids Res   2004 ; 32:2441 -52; PMID :15121901 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Genes Dev  2013 ; 27:2227 - 32; PMID:24105744 ; http://dx.doi.org/10.1101/ gad.224923.11325.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nat Rev Mol Cell Biol   2006 ; 7:529-39; PMID:16829983 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
RNA  Biol 2011 ; 8:61-6; PMID:21289487 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nucleic Acids Res  2000 ; 28:1684 - 91; PMID:10734186 ; http://dx.doi.org/10.1093/ nar/28.8.1684 28.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nature   2001 ; 413:538-42; PMID :11586364 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nucleic  Acids Res  2010 ; 38:8015 -26; PMID:20699273 ;  http://dx.doi.org/10.1093/nar/gkq703 31.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
EMBO J   2002 ; 21:165-74; PMID:11782436 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Hum Mol Genet  2009 ;  18:3384 -96; PMID :19515850 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nat Rev Mol Cell Biol   2007 ; 8:947-56; PMID:18000527 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Mol  Cell 2005 ; 18:1-12; PMID:15808504 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
J Biol Chem  2000 ; 275:6252 - 8; PMID:10692421 ; http://dx.doi.org/10.1074/ jbc.275.9.6252 38.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Diabetes Metab Res Rev   2008 ; 24:93-102; PMID:17990297 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Sci Signal  2009 ; 2:ra24 ;  PMID:19471022 ; http://dx.doi.org/10.1126/ scisignal.200028241.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
EMBO Rep   2011 ; 12:142-8; PMID:21252943 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Brain Res Rev  2010 ; 64:195-212; PMID:20382182 ;  http://dx.doi.org/10.1016/j.brainresrev.2010.04.002 43.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Neuromolecular Med  2013 ; 15:677- 91; PMID:23907729 ; http://dx.doi.org/10.1007/ s12017-013-8252-z 44.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
J Cell Sci  2013 ; 126:5284 -92;  PMID:24046452 ; http://dx.doi.org/10.1242/ jcs.133744 45.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Mol Cell  2013 ;  49:795-807; PMID:23416108 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nature  2009 ; 462:935- 9; PMID:20016603 ; http://dx.doi.org/10.1038/ nature08657 47.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
PLoS Biol  2009 ; 7:e1000252 ; PMID:19956565 ;  http://dx.doi.org/10.1371/journal.pbio.1000252 49.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Front Genet  2013 ; 4:45; PMID:23554604 ;  http://dx.doi.org/10.3389/fgene.2013.00045 50.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Int Rev Cell Mol Biol  2011 ; 288:167- 83; PMID:21482412 ; http://dx.doi.org/10.1016/ B978-0-12-386041-5.00004-2 51.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Biochim Biophys Acta  2007 ;  1773 :694-706; PMID:17475350 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Glia  2011 ; 59:1719 -31; PMID:21769946 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Neuroreport   2002 ; 13:2359 -64; PMID:12488827 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Biochem Biophys Res  Commun  2010 ; 393:280-5; PMID:20132795 ;  http://dx.doi.org/10.1016/j.bbrc.2010.01.122 55.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Biochem Biophys Res Commun  2006 ; 347:406- 12; PMID:16828461 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Prog Neurobiol   2011 ; 94:166-200; PMID:21550379 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Cell 2007 ; 130:991- 1004 ; PMID:17889645 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nat Rev Neurosci  2009 ; 10:100- 12; PMID:19145234 ; http://dx.doi.org/10.1038/ nrn2559 60.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Annu Rev Pathol  2012 ; 7:303- 21; PMID:22035194 ; http://dx.doi.org/10.1146/ annurev-pathol-011811-132509 61.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
J Cell Biol  2007 ; 177:969- 79; PMID:17562789 ; http://dx.doi.org/10.1083/ jcb.200701042 62.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Neurogenetics  2010 ; 11:91-100; PMID:19593598 ;  http://dx.doi.org/10.1007/s10048-009-0206-0 63.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Biomed  Res Int  2013 ; 2013 :730714 ; PMID:24083238 ;  http://dx.doi.org/10.1155/2013/730714 64.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Annu Rev Genet  2007 ; 41:169-92;  PMID:17608616 ; http://dx.doi.org/10.1146/ annurev.genet.41.042007.16590065.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Hum Genet  1984 ; 67:136- 42; PMID:6430783 ; http://dx.doi.org/10.1007/ BF00272988 66.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
"Mol Cell  2011 ; 44:966-77; PMID:22195969 ;  http://dx.doi.org/10.1016/j.molcel.2011.10.013 67.Wongsurawat  T, Jenjaroenpun  P, Kwoh  CK, Kuznetsov   V. Quantitative model of R-loop forming structures  reveals a novel level of RNA-DNA interactome  complexity.",OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nucleic Acids Res  2012 ; 40:e16;  PMID:22121227 ; http://dx.doi.org/10.1093/nar/ gkr1075 68.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Mol Cell  2005 ; 18:711- 22; PMID:15949445 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
PLoS One   2013 ; 8:e65541 ; PMID:23762389 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
BMC Neurosci   2009 ; 10:12; PMID:19228403 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
FASEB J  2003 ; 17:1195 -214;  PMID:12832285 ; http://dx.doi.org/10.1096/ fj.02-0752rev72.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Biogerontology  2005 ; 6:233-43; PMID:16333757 ;  http://dx.doi.org/10.1007/s10522-005-2624-1 73.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
EMBO Rep   2009 ; 10:887-93; PMID:19557000 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nucleic  Acids Res  2013 ; 41:10110 -23; PMID:23999093 ;  http://dx.doi.org/10.1093/nar/gkt778 75.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Nat Cell Biol   2009 ; 11:1315 -24; PMID:19838172 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Neurotoxicol Teratol  2007 ; 29:1-9; PMID:17222532 ;  http://dx.doi.org/10.1016/j.ntt.2006.11.006 77.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Mech Ageing Dev  2001 ; 123:21- 7; PMID:11640948 ; http://dx.doi.org/10.1016/ S0047-6374(01)00336-0 78.,OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
Neuropathol  Appl Neurobiol  2013 ; 39:45-50; PMID:23339288 ;  http://dx.doi.org/10.1111/nan.12017 79.,Non-OADS,/arxiv_data1/oa_pdf/78/71/rdis-2-e27744.PMC4091563.pdf
"Plant Signaling &  Behavior 2014; 9:e28839; PMID: 24739470; http://dx.doi.org/10.4161/psb.28839Regulation of senescence under elevated  atmospheric CO2 via ubiquitin modification Shoki Aoyama, Yu Lu, Junji Yamaguchi, and Takeo Sato* Faculty of Science and Graduate School of Life Science; Hokkaido University; Kita-ku Sapporo, Japan Keywords:  C/N balance, carbon metabolism, nutrient, ubiquitin ligase, biomass elevated atmospheric CO2 concentration is a serious  global environmental problem.",Non-OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Physiol 2002;  128:472-81;  PMID :11842151 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Curr Opin Plant Biol 2001; 4:247-53;   PMID:11312136 ; http://dx.doi.org/10.1016/ S1369-5266(00)00168-0 3.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Cell Environ 2007; 30:1126-49;  PMID:17661751 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
J Exp Bot 2007;  58:2297-306;  PMID:17519352 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
J Exp Bot 2011;  62:1399-409;  PMID:21196475 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant J 2004; 39:847-62;  PMID :15341628 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Annu Rev Plant Biol 2004; 55:591- 628; PMID:15377233 ; http://dx.doi.org/10.1146/ annurev.arplant.55.031903.141610 8.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
J Exp Bot  2011; 62:1523-30;  PMID:21177259 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Nature 2011;  475:177-8;  PMID:21753843 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Cell Physiol 2014; 55:281-92;   PMID:24319077 ; http://dx.doi.org/10.1093/pcp/ pct186 11.,Non-OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Cell Physiol 2014; 55:306-19;   PMID:24343996 ; http://dx.doi.org/10.1093/pcp/ pct19212.,Non-OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Physiol  1998 ; 116 :715-23 ;  PMID:9489018 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Science 2010;  328:899-903;  PMID:20466933 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Cell Physiol 2014; 55:269-80;   PMID:24401956 ; http://dx.doi.org/10.1093/pcp/ pcu001 16.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Cell Physiol 2014; 55:293-305;  PMID:24399238 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
J Biol Chem 2004; 279:16598-605; PMID:14757761 ;  http://dx.doi.org/10.1074/jbc.M313710200 19.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Planta  2004; 219:765-72;  PMID:15118859 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
J Exp Bot  2006; 57:391-9;  PMID :16157653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Physiol 2012; 158:1241-51;  PMID:22247267 ;  http://dx.doi.org/10.1104/pp.111.191908 23.,Non-OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Physiol 2013; 162:1290-310; PMID:23696093 ; http://dx.doi.org/10.1104/ pp.113.217380 24.,Non-OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant J 2009; 60:852-64;  PMID:19702666 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
J Mol Evol  2006; 62:434-45;  PMID:16557337 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Signal Behav 2012; 7:1014-21; PMID:22827943 ; http://dx.doi.org/10.4161/ psb.20851 27.,Non-OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant J  2011; 68:137-46;  PMID:21668537 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant J 2007;  50:320-37;  PMID:17355433 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
PLoS Genet 2011; 7:e1002021; PMID:21455488 ;  http://dx.doi.org/10.1371/journal.pgen.1002021,Non-OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Cell 2013; 25:4061-74;   PMID:24122828 ; http://dx.doi.org/10.1105/ tpc.113.116012 33.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Cell 2012; 24:2168-83; PMID:22634761 ; http://dx.doi.org/10.1105/ tpc.112.096636 34.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Physiol 2009;  151:2120-32 ;  PMID:19854858 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Cell  2014; 26:454-64;  PMID:24474629 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Nat Rev Mol Cell Biol 2009; 10:550-63;   PMID:19626045 ; http://dx.doi.org/10.1038/ nrm2731 37.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Cell 2013; 25:2236-52; PMID:23800962 ; http://dx.doi.org/10.1105/ tpc.113.11339938.,OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
Plant Physiol 2014; 164:879-87; PMID:24394775 ;  http://dx.doi.org/10.1104/pp.113.230995 39.,Non-OADS,/arxiv_data1/oa_pdf/bf/67/psb-9-e28839.PMC4091564.pdf
"Homozygous  dNf1  null mutants are viable and fertile,  but show a 15–20% reduction in linear A Drosophila  screen identifies neurofibromatosis-1 genetic modifiers  involved in systemic and synaptic growth James A Walker1,2,* and André Bernards1,2,* 1Massachusetts General Hospital Center for Cancer Research and Harvard Medical School; Charlestown, MA USA; 2Center for Human Genetic Research;  Massachusetts General Hospital; Boston, MA USA Keywords:  cAMP/PKA signaling, Drosophila melanogaster, genetic model, neurofibromatosis, Ras signaling, synaptic morphology Abbreviations:  NF1, Neurofibromatosis type 1; GAP, GTPase activating protein; ALK, anaplastic lymphoma kinase; CNS, central  nervous system; NMJ, neuromuscular junction *Correspondence to: James A Walker; Email:  jwalker@helix.mgh.harvard.edu; André Bernards;  Email: abernards@helix.mgh.harvard.edu Submitted: 01/06/2014; Revised:  02/12/2014; Accepted: 02/24/2014;  Published Online: 02/25/2014 http://dx.doi.org/10.4161/rdis.28341 Addendum to: Walker JA, Gouzi JY, Long JB,  Huang S, Maher RC, Xia H, Khalil K, Ray A, Van  Vactor D, Bernards R, et al.",Non-OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
PLoS Genet 2013; 9:e1003958;  PMID:24278035; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Annu Rev  Genomics Hum Genet 2013; 14:355-69;   PMID:23875798 ; http://dx.doi.org/10.1146/ annurev-genom-091212-153523 2.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Handb Clin Neurol  2013; 111:333-40;  PMID:23622184 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Cell 2001; 104:593- 604; PMID :11239415 ; http://dx.doi.org/10.1016/ S0092-8674(01)00245-8 4.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Hum Mol Genet  2006; 15:1087-98;  PMID:16513807 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
J Neurosci 2007; 27:6852- 7; PMID:17581973 ; http://dx.doi.org/10.1523/ JNEUROSCI.0933-07.2007 6.,Non-OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Nature 2000;  403:895-8;  PMID:10706287 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Science  2001; 293:2251-6;  PMID :11567138 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Genes Dev 2006; 20:3311- 23; PMID:17114577 ; http://dx.doi.org/10.1101/ gad.1466806 13.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
PLoS Genet  2013; 9:e1003958;  PMID:24278035 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Nat Neurosci 2002; 5:95-6;   PMID:11788835 ; http://dx.doi.org/10.1038/nn792 16.,Non-OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
J Neurosci 2012; 32:16971- 81; PMID:23175848 ; http://dx.doi.org/10.1523/ JNEUROSCI.1756-12.2012 17.,Non-OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Nature 2004; 430:345- 50; PMID:15208641 ; http://dx.doi.org/10.1038/ nature02647 18.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Development  2010; 137:3523-33;  PMID:20876658 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Dev Neurobiol 2013; 73:189- 208; PMID :22949158 ; http://dx.doi.org/10.1002/ dneu.22056 20.,Non-OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
J Biomed Sci 2007; 14:461-6;  PMID:17370141 ;  http://dx.doi.org/10.1007/s11373-007-9158-2 21.,Non-OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Dev Dyn 1992; 195:216- 26; PMID:1301085 ; http://dx.doi.org/10.1002/ aja.1001950307 23.,Non-OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Oncogene 1997; 14:439-49;  PMID:9053841 ;  http://dx.doi.org/10.1038/sj.onc.1200849 24.,Non-OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Cell 2010; 142:218-29;  PMID:20655465 ;  http://dx.doi.org/10.1016/j.cell.2010.06.004 25.,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Cancer Discov 2012; 2:495-502;   PMID:22614325 ; http://dx.doi.org/10.1158/2159- 8290.CD-12-0009 26.,Non-OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
Oncogene 2001; 20:97-105;  PMID:11244508 ;  http://dx.doi.org/10.1038/sj.onc.1204026,OADS,/arxiv_data1/oa_pdf/1d/28/rdis-2-e28341.PMC4091572.pdf
"Plant Signaling & Behavior 2014; 9:e29057; PMID: 24801518; http://dx.doi.org/10.4161/psb.29057Lack of malate valve capacities lead to improved  N-assimilation and growth in transgenic   A. thaliana  plants Jennifer Selinski and r enate Scheibe* Department of Plant Physiology; u niversity of o snabrueck; o snabrueck, Germany Keywords:  malate valve, plastidial glycolysis, ammonium assimilation, nitrate assimilation, energy supply, redox-balance Abbreviations:  1,3bisPGA, 1,3-bisphosphoglycerate; 2-OG, 2-oxoglutarate; 3-PGA, 3-phosphoglycerate; Fd, ferredoxin; GAPDH,  glyceraldehyde-3-phosphate dehydrogenase; GDC, glycine decarboxylase; Gln, glutamine; GLT1, NADH-GOGAT; Glu,  glutamate; GLU1/2, Fd-GOGAT1/2; GOGAT, glutamate synthase; GS, glutamine synthetase; MDH, malate dehydrogenase;  MNE, mean normalized expression; NiR, nitrite reductase; NR, nitrate reductase; OAA, oxaloacetate; OPP, oxidative pentose- phosphate pathway; PET, photosynthetic electron transport; TP, triose phosphate in this study we analyzed the relationship between malate valve capacities, n-assimilation, and energy metabolism.",OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Gene 1997; 199:145-8; PMID:9358050 ;  http://dx.doi.org/10.1016/S0378-1119(97)00361-2 2.,OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
"A novel, non-redox-regulated NAD-dependent malate dehy - drogenase from chloroplasts of Arabidopsis thaliana  L.  J Biol Chem 1998; 273:27927-33; PMID:9774405 ;  http://dx.doi.org/10.1074/jbc.273.43.27927 4.",Non-OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Physiol Plant 2004; 120:21-6; PMID:15032873 ;  http://dx.doi.org/10.1111/j.0031-9317.2004.0222.x 6.,OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Arch Biochem Biophys 1995; 324:201-8; PMID:8554310 ; http://dx.doi.org/10.1006/ abbi.1995.00318.,Non-OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Planta 1998; 205:359-66;  http://dx.doi.org/10.1007/s004250050331 9.,Non-OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Plant Physiol 2009; 151:541- 58; PMID:19675149 ; http://dx.doi.org/10.1104/ pp.109.143701 10.,Non-OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Plant Physiol 2010; 152:1830-41; PMID:20107025 ; http://dx.doi.org/10.1104/ pp.109.150458 11.,Non-OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Mol Plant 2014; 7:170-86; PMID:24198233 ;  http://dx.doi.org/10.1093/mp/sst151 12.,OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
J Exp Bot  2012; 63:1445-59;  PMID:22140244 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Bioinformatics 2003; 19:1439-40; PMID:12874059 ; http://dx.doi.org/10.1093/ bioinformatics/btg15714.,OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Plant J 2002; 29:347-58; PMID:11844111 ;  http://dx.doi.org/10.1046/j.1365-313X.2002.01218.x 15.,OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Physiol Plant 2014; •••: http://dx.doi.org/10.1111/ ppl.12177 ; PMID:24576214 16.,OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Arch Biochem Biophys 1995; 324:201-8; PMID:8554310 ; http://dx.doi.org/10.1006/ abbi.1995.0031 18.,Non-OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Bot Acta 1994; 107:313-20; http://dx.doi.org/10.1111/j.1438-8677.1994.tb00801.x 19.,OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Physiol Plant  2008; 133:584-98;  PMID:18494733 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/1a/psb-9-e29057.PMC4091578.pdf
Clinical Trials Registration .www.clinicaltrials.gov (NCT01328041) and http://www.gsk-clinicalstudywww.gsk- clinicalstudyregister.com (112574).,OADS,/arxiv_data1/oa_pdf/28/cf/jiu051.PMC4091579.pdf
Available at: http://hivdb.stanford.edu/ .,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jiu051.PMC4091579.pdf
Availableat:http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegu latoryInformation/Guidances/UCM355128.pdf .,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jiu051.PMC4091579.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/0a/jiu105.PMC4091581.pdf
Available at: http://www.who.int/in ﬂuenza/ human_animal_interface/in ﬂuenza_h7n9/10u_ReportWebH7N9 Number.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b1/0a/jiu105.PMC4091581.pdf
Available at: http://www.who.int/csr/don/archive/year/2014/en/ index.html .,OADS,/arxiv_data1/oa_pdf/b1/0a/jiu105.PMC4091581.pdf
"OncoImmunology 2014; 3:e28927; http://dx.doi.org/10.4161/onci.28927Ménage à trois Sustained therapeutic anti-tumor immunity requires  multiple partners in malignant glioma Derek A wa inwright and Maciej  s  Lesniak* th e Brain tu mor Center; th e un iversity of Chicago Pritzker sc hool of Medicine; Chicago, iL usA Keywords:  immunosuppression, tryptophan, glioblastoma, metabolism, immunotherapy Glioblastoma is an aggressive primary brain cancer.",Non-OADS,/arxiv_data1/oa_pdf/ae/59/onci-3-e28927.PMC4091585.pdf
N Engl J Med 2005; 352:987-96; PMID:15758009 ; http://dx.doi.org/10.1056/ NEJMoa043330 2.,OADS,/arxiv_data1/oa_pdf/ae/59/onci-3-e28927.PMC4091585.pdf
J Neurosurg 2002; 96:580-4; PMID:11883844 ;  http://dx.doi.org/10.3171/jns.2002.96.3.0580 3.,OADS,/arxiv_data1/oa_pdf/ae/59/onci-3-e28927.PMC4091585.pdf
Neuro Oncol 2006; 8:234-43;  PMID:16723631 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/59/onci-3-e28927.PMC4091585.pdf
